Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Arrhythmias

  Free Subscription


Articles published in Int J Cardiol

Retrieve available abstracts of 408 articles:
HTML format
Text format



Single Articles


    November 2018
  1. WANG H, Wang S, Sun Y
    Could red blood cell distribution width predict high CHADS2 and CHADS2-VASC score in adults with atrial fibrillation? A focus on the general population.
    Int J Cardiol. 2018;271:345.
    PubMed     Text format    


  2. AMIN AS, Wilde AAM, Tan HL
    Response to letter from Drs. Li et al. regarding our paper in Int. J. Cardiol. 2018. Doi: 10.1016/j.ijcard.2017.09.010: SCN5A mutation type and topology are associated with the risk of ventricular arrhythmia by sodium channel blockers.
    Int J Cardiol. 2018;271:124.
    PubMed     Text format    


  3. WANG Y, Wang C, Zhang Y, Hong F, et al
    The new evidence on cryoballoon ablation to persistent atrial fibrillation.
    Int J Cardiol. 2018;271:121.
    PubMed     Text format    


  4. JIANG P, Wu J, Guo S, He Y, et al
    Atrial fibrillation and sleep apnea: A chicken and egg situation.
    Int J Cardiol. 2018;271:120.
    PubMed     Text format    


  5. LI J, Wang X, Sun M, Yan G, et al
    "Rebound" hypercoagulability after interruption of anticoagulation in patients with atrial fibrillation.
    Int J Cardiol. 2018;271:119.
    PubMed     Text format    


  6. PATTI G, Pecen L, Lucerna M, Huber K, et al
    Outcomes of anticoagulated patients with atrial fibrillation treated with or without antiplatelet therapy - A pooled analysis from the PREFER in AF and PREFER in AF PROLONGATON registries.
    Int J Cardiol. 2018;270:160-166.
    PubMed     Text format     Abstract available


  7. GUENANCIA C, Dargent A, Large A, Andreu P, et al
    New-onset atrial fibrillation in ICU: A FROG in the throat.
    Int J Cardiol. 2018;270:189.
    PubMed     Text format    


  8. MERT GO, Mert KU, Gorenek B
    Success predictor of cryoballoon ablation in atrial fibrillation: Left atrial volume vs area.
    Int J Cardiol. 2018;270:188.
    PubMed     Text format    


  9. KIMURA T, Kohno T, Fukunaga K, Yamasawa W, et al
    Author's reply: Atrial fibrillation and sleep apnea: A chicken and egg situation.
    Int J Cardiol. 2018;270:187.
    PubMed     Text format    


    October 2018
  10. TELLES-GARCIA N, Dahal K, Kocherla C, Lip GYH, et al
    Non-vitamin K antagonists oral anticoagulants are as safe and effective as warfarin for cardioversion of atrial fibrillation: A systematic review and meta-analysis.
    Int J Cardiol. 2018;268:143-148.
    PubMed     Text format     Abstract available


  11. FANGEL MV, Nielsen PB, Larsen TB, Christensen B, et al
    Type 1 versus type 2 diabetes and thromboembolic risk in patients with atrial fibrillation: A Danish nationwide cohort study.
    Int J Cardiol. 2018;268:137-142.
    PubMed     Text format     Abstract available


  12. OWEN HJ, Bos JM, Ackerman MJ
    Wearable cardioverter defibrillators for patients with long QT syndrome.
    Int J Cardiol. 2018;268:132-136.
    PubMed     Text format     Abstract available


  13. XING Y, Xu B, Sheng X, Xu C, et al
    Transformation from persistent atrial fibrillation to paroxysmal type after initial ablation predicts success of repeated ablation.
    Int J Cardiol. 2018;268:120-124.
    PubMed     Text format     Abstract available


    September 2018
  14. PAPAGEORGIOU N, Lim WY, Schilling RJ
    Atrial fibrillation in acute coronary syndromes: Could white blood cell count be the link?
    Int J Cardiol. 2018 Sep 21. pii: S0167-5273(18)34829.
    PubMed     Text format    


  15. LI YG, Lip GYH
    Stroke prevention in atrial fibrillation: State of the art.
    Int J Cardiol. 2018 Sep 19. pii: S0167-5273(18)32178.
    PubMed     Text format     Abstract available


  16. GUTTMANN OP
    Atrial fibrillation and thromboembolism in hypertrophic cardiomyopathy - An underestimated risk.
    Int J Cardiol. 2018 Sep 19. pii: S0167-5273(18)35180.
    PubMed     Text format    


  17. SVINGEN GFT, Zuo H, Ueland PM, Seifert R, et al
    Increased plasma trimethylamine-N-oxide is associated with incident atrial fibrillation.
    Int J Cardiol. 2018;267:100-106.
    PubMed     Text format     Abstract available


  18. HAUGAA KH, Stokke MK
    Cardiac electrical and mechanical alterations - united in the long QT syndrome.
    Int J Cardiol. 2018 Sep 15. pii: S0167-5273(18)34824.
    PubMed     Text format    


  19. GRYMONPREZ M, Vakaet V, Kavousi M, Stricker BH, et al
    Chronic obstructive pulmonary disease and the development of atrial fibrillation.
    Int J Cardiol. 2018 Sep 15. pii: S0167-5273(18)32860.
    PubMed     Text format     Abstract available


  20. STEWART COATS AJ
    The enigma of beta-blockers, atrial fibrillation and heart failure.
    Int J Cardiol. 2018 Sep 15. pii: S0167-5273(18)34869.
    PubMed     Text format    


  21. WEBER C, Hung J, Hickling S, Li I, et al
    Drivers of hospitalisation trends for non-valvular atrial fibrillation in Western Australia, 2000-2013.
    Int J Cardiol. 2018 Sep 13. pii: S0167-5273(18)33943.
    PubMed     Text format     Abstract available


  22. GIUDICESSI JR, Rohatgi RK, Bos JM, Ackerman MJ, et al
    Prevalence and clinical phenotype of concomitant long QT syndrome and arrhythmogenic bileaflet mitral valve prolapse.
    Int J Cardiol. 2018 Sep 11. pii: S0167-5273(18)34953.
    PubMed     Text format     Abstract available


  23. VAN DOORN S, Rutten FH, O'Flynn CM, Oudega R, et al
    Effectiveness of CHA2DS2-VASc based decision support on stroke prevention in atrial fibrillation: A cluster randomised trial in general practice.
    Int J Cardiol. 2018 Sep 8. pii: S0167-5273(18)33685.
    PubMed     Text format     Abstract available


  24. MARUM AA, Silva BA, Bortolotto AL, Silva AC, et al
    Optimizing flecainide plasma concentration profile for atrial fibrillation conversion while minimizing adverse ventricular effects by rapid, low-dose intratracheal or intravenous administration.
    Int J Cardiol. 2018 Sep 8. pii: S0167-5273(18)34561.
    PubMed     Text format     Abstract available


  25. JENABI E
    Comment on "Non-vitamin K antagonists oral anticoagulants are as safe and effective as warfarin for cardioversion of atrial fibrillation: A systematic review and meta-analysis".
    Int J Cardiol. 2018 Sep 5. pii: S0167-5273(18)34785.
    PubMed     Text format    


  26. BRIONGOS-FIGUERO S, Estevez A, Luisa Perez M, Martinez-Ferrer JB, et al
    Survival and arrhythmic risk among ischemic and non-ischemic heart failure patients with prophylactic implantable cardioverter defibrillator only therapy: A propensity score-matched analysis.
    Int J Cardiol. 2018 Sep 5. pii: S0167-5273(18)34159.
    PubMed     Text format     Abstract available


  27. ARRIGO M, Ishihara S, Feliot E, Rudiger A, et al
    New-onset atrial fibrillation in critically ill patients and its association with mortality: A report from the FROG-ICU study.
    Int J Cardiol. 2018;266:95-99.
    PubMed     Text format     Abstract available


  28. CASTELLETTI S, Dagradi F, Goulene K, Danza AI, et al
    A wearable remote monitoring system for the identification of subjects with a prolonged QT interval or at risk for drug-induced long QT syndrome.
    Int J Cardiol. 2018;266:89-94.
    PubMed     Text format     Abstract available


  29. AESCHBACHER S, O'Neal WT, Krisai P, Loehr L, et al
    Relationship between QRS duration and incident atrial fibrillation.
    Int J Cardiol. 2018;266:84-88.
    PubMed     Text format     Abstract available


  30. NAKAMURA K, Funabashi N, Naito S, Uehara M, et al
    Reply to letter "anatomical relationship of coronary sinus/great cardiac vein and LCx artery along mitral annulus in atrial-fibrillation before radiofrequency catheter ablation using 320-slice CT".
    Int J Cardiol. 2018;266:160.
    PubMed     Text format    


  31. RIENSTRA M, van Veldhuisen DJ
    Atrial fibrillation is more troublesome in heart failure patients with preserved compared to those with reduced ejection fraction.
    Int J Cardiol. 2018;266:155-156.
    PubMed     Text format    


  32. KADHIM K, Lau DH, Linz D, Sanders P, et al
    Improved survival and reduced stroke risk in patients with atrial fibrillation: Is catheter ablation winning the rhythm-control race?
    Int J Cardiol. 2018;266:153-154.
    PubMed     Text format    


  33. STROKER E, de Asmundis C, Chierchia GB
    Cryoballoon ablation for the treatment of atrial fibrillation: Does it stand the test of time?
    Int J Cardiol. 2018;266:151-152.
    PubMed     Text format    


  34. BALIK M
    New-onset atrial fibrillation in critically ill patients - Implications for rhythm rather than rate control therapy?
    Int J Cardiol. 2018;266:147-148.
    PubMed     Text format    


  35. VERRIER RL
    The power of the patch: A smart way to track risk for Torsades de pointes in congenital and drug-induced long QT syndromes?
    Int J Cardiol. 2018;266:145-146.
    PubMed     Text format    


  36. HEIJMAN J, Dobrev D, Crijns HJGM
    Electrocardiographic characteristics associated with atrial fibrillation - What do they tell us?
    Int J Cardiol. 2018;266:143-144.
    PubMed     Text format    


  37. BARRA S, Baran J, Narayanan K, Boveda S, et al
    Association of catheter ablation for atrial fibrillation with mortality and stroke: A systematic review and meta-analysis.
    Int J Cardiol. 2018;266:136-142.
    PubMed     Text format     Abstract available


  38. RIVASI G, Solari D, Rafanelli M, Ceccofiglio A, et al
    Incidence and predictors of syncope recurrence after cardiac pacing in patients with carotid sinus syndrome.
    Int J Cardiol. 2018;266:119-123.
    PubMed     Text format     Abstract available


  39. GOYAL P, Almarzooq ZI, Cheung J, Kamel H, et al
    Atrial fibrillation and heart failure with preserved ejection fraction: Insights on a unique clinical phenotype from a nationally-representative United States cohort.
    Int J Cardiol. 2018;266:112-118.
    PubMed     Text format     Abstract available


  40. AKKAYA E, Berkowitsch A, Zaltsberg S, Greiss H, et al
    Five-year outcome and predictors of success after second-generation cryoballoon ablation for treatment of symptomatic atrial fibrillation.
    Int J Cardiol. 2018;266:106-111.
    PubMed     Text format     Abstract available


  41. GRIMALDI-BENSOUDA L, Wedemeyer H, Wiegand J, Lohse AW, et al
    Dronedarone, amiodarone and other antiarrhythmic drugs, and acute liver injuries: a case-referent study.
    Int J Cardiol. 2018;266:100-105.
    PubMed     Text format     Abstract available


  42. JONES DA, Rathod KS, Williamson A, Harrington D, et al
    The effect of intracoronary sodium nitrite on the burden of ventricular arrhythmias following primary percutaneous coronary intervention for acute myocardial infarction.
    Int J Cardiol. 2018;266:1-6.
    PubMed     Text format     Abstract available


  43. LI YG, Miyazawa K, Wolff A, Zubaid M, et al
    One-year risks of stroke and mortality in patients with atrial fibrillation from different clinical settings: The Gulf SAFE registry and Darlington AF registry.
    Int J Cardiol. 2018 Sep 1. pii: S0167-5273(18)34355.
    PubMed     Text format     Abstract available


    August 2018
  44. RAVERA M, Bussalino E, Paoletti E, Bellasi A, et al
    Haemorragic and thromboembolic risk in CKD patients with non valvular atrial fibrillation: Do we need a novel risk score calculator?
    Int J Cardiol. 2018 Aug 31. pii: S0167-5273(18)33747.
    PubMed     Text format     Abstract available


  45. HIGASHI Y
    Does renal function have incremental predictive value of stroke in atrial fibrillation?
    Int J Cardiol. 2018 Aug 29. pii: S0167-5273(18)34620.
    PubMed     Text format    


  46. GOEL A, Agnihotri K, Ashish K, Subramany S, et al
    Novel biomarkers for atrial fibrillation: A recent update.
    Int J Cardiol. 2018 Aug 25. pii: S0167-5273(18)34943.
    PubMed     Text format    


  47. CAMM CF, Russell E, Ji Xu A, Rajappan K, et al
    Does YouTube provide high-quality resources for patient education on atrial fibrillation ablation?
    Int J Cardiol. 2018 Aug 24. pii: S0167-5273(18)33338.
    PubMed     Text format     Abstract available


  48. PARK JW, Sievert H, Kleinecke C, Vaskelyte L, et al
    Left atrial appendage occlusion with lambre in atrial fibrillation: Initial European experience.
    Int J Cardiol. 2018;265:97-102.
    PubMed     Text format     Abstract available


  49. CHAN YH, Yeh YH, Hsieh MY, Chang CY, et al
    The risk of acute kidney injury in Asians treated with apixaban, rivaroxaban, dabigatran, or warfarin for non-valvular atrial fibrillation: A nationwide cohort study in Taiwan.
    Int J Cardiol. 2018;265:83-89.
    PubMed     Text format     Abstract available


  50. JIANG P, Yang FO, Wu J, He Y, et al
    Left atrial low-voltage areas: A powerful predictor in paroxysmal atrial fibrillation recurrence after catheter ablation?
    Int J Cardiol. 2018;265:238.
    PubMed     Text format    


  51. MASUDA M
    Reply to the letter to the editor: "Left atrial low-voltage areas predict atrial fibrillation recurrence after catheter ablation in patients with paroxysmal atrial fibrillation".
    Int J Cardiol. 2018;265:134.
    PubMed     Text format    


  52. PATTI G, Cavallari I, Hanon O, De Caterina R, et al
    The safety and efficacy of non-vitamin K antagonist oral anticoagulants in atrial fibrillation in the elderly.
    Int J Cardiol. 2018;265:118-124.
    PubMed     Text format     Abstract available


  53. KATSIKI N, Mikhailidis DP, Papanas N
    Left atrial volume: An independent predictor of cardiovascular outcomes.
    Int J Cardiol. 2018;265:234-235.
    PubMed     Text format    


  54. EMDIN M, Aimo A, Mirizzi G, Piacenti M, et al
    Is fat good for arrhythmias in ischemic heart failure? Another face of the obesity paradox.
    Int J Cardiol. 2018;265:169-170.
    PubMed     Text format    


  55. CHANG TY, Lin CY, Chen SA
    Vagal impact of cryoballoon ablation during pulmonary vein isolation.
    Int J Cardiol. 2018;265:132-133.
    PubMed     Text format    


  56. DE SENSI F, Berruezo A
    Pulmonary vein potentials during cryoballoon ablation of atrial fibrillation. If you don't see them, look forward...and make a good lesion!
    Int J Cardiol. 2018 Aug 13. pii: S0167-5273(18)34451.
    PubMed     Text format    


  57. MCCABE PJ
    Moving beyond description to intervention to improve self-management knowledge for patients with atrial fibrillation.
    Int J Cardiol. 2018 Aug 13. pii: S0167-5273(18)34436.
    PubMed     Text format    


  58. BOGEHOLZ N, Dechering DG, Eckardt L
    Improved risk stratification for patients with atrial fibrillation by advancing the concept of atrial cardiomyopathy?
    Int J Cardiol. 2018 Aug 11. pii: S0167-5273(18)34360.
    PubMed     Text format    


  59. POTPARA TS, Mujovic N, Sivasambu B, Shantsila A, et al
    Validation of the MB-LATER score for prediction of late recurrence after catheter-ablation of atrial fibrillation.
    Int J Cardiol. 2018 Aug 11. pii: S0167-5273(18)34388.
    PubMed     Text format     Abstract available


  60. CHOI YJ, Choi EK, Han KD, Jung JH, et al
    Temporal trends of the prevalence and incidence of atrial fibrillation and stroke among Asian patients with hypertrophic cardiomyopathy: A nationwide population-based study.
    Int J Cardiol. 2018 Aug 11. pii: S0167-5273(18)33740.
    PubMed     Text format     Abstract available


  61. BARANCHUK A, Yeung C
    Advanced interatrial block predicts atrial fibrillation recurrence across different populations: Learning Bayes syndrome.
    Int J Cardiol. 2018 Aug 10. pii: S0167-5273(18)34711.
    PubMed     Text format    


  62. PAVLICEK V, Kindermann I, Wintrich J, Mahfoud F, et al
    Ventricular arrhythmias and myocardial inflammation: Long-term follow-up of patients with suspected myocarditis.
    Int J Cardiol. 2018 Aug 9. pii: S0167-5273(18)31893.
    PubMed     Text format     Abstract available


  63. CAMPODONICO J, Piepoli M, Clemenza F, Bonomi A, et al
    Dose-dependent efficacy of beta-blocker in patients with chronic heart failure and atrial fibrillation.
    Int J Cardiol. 2018 Aug 6. pii: S0167-5273(18)34278.
    PubMed     Text format     Abstract available


  64. RUBBOLI A
    Oral anticoagulation alone for concomitant stable coronary artery disease and atrial fibrillation: A definitive strategy?
    Int J Cardiol. 2018;264:95-96.
    PubMed     Text format    


  65. FRIBERG L
    Safety of apixaban in combination with dronedarone in patients with atrial fibrillation.
    Int J Cardiol. 2018;264:85-90.
    PubMed     Text format     Abstract available


  66. FISCHER Q, Georges JL, Le Feuvre C, Sharma A, et al
    Optimal long-term antithrombotic treatment of patients with stable coronary artery disease and atrial fibrillation: "OLTAT registry".
    Int J Cardiol. 2018;264:64-69.
    PubMed     Text format     Abstract available


  67. PASTORI D, Lip GYH, Farcomeni A, Del Sole F, et al
    Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants.
    Int J Cardiol. 2018;264:58-63.
    PubMed     Text format     Abstract available


  68. EL-BATTRAWY I, Borggrefe M, Akin I
    Sleep apnea as an attributable risk for atrial fibrillation.
    Int J Cardiol. 2018;264:103.
    PubMed     Text format    


  69. POPPE KK, Doughty RN
    Response to letter from El-Battrawy et al.: Sleep apnea as an attributable risk for atrial fibrillation.
    Int J Cardiol. 2018;264:102.
    PubMed     Text format    


  70. OZEKE O, Aras D, Cay S, Ozcan F, et al
    Ajmaline-induced Epsilon wave: Its role is not only for diagnosis but also for risk stratification.
    Int J Cardiol. 2018;264:99.
    PubMed     Text format    


  71. EHRLICH JR
    Re-gaining confidence in contemporary dronedarone use.
    Int J Cardiol. 2018;264:97-98.
    PubMed     Text format    


  72. MARIN F, Roldan V
    Oral anticoagulation and comorbidities; too many details for clinical practice?
    Int J Cardiol. 2018;264:93-94.
    PubMed     Text format    


  73. THERASSE D, Probst V, Gourraud JB
    Sodium channel blocker challenge in Brugada syndrome: Role in risk stratification.
    Int J Cardiol. 2018;264:100-101.
    PubMed     Text format    


    July 2018
  74. D'ONOFRIO A, Pieragnoli P, Biffi M, Nigro G, et al
    Subcutaneous implantable cardioverter defibrillator implantation: An analysis of Italian clinical practice and its evolution.
    Int J Cardiol. 2018 Jul 31. pii: S0167-5273(18)33995.
    PubMed     Text format     Abstract available


  75. VEDOVATI MC, Giustozzi M, Verdecchia P, Pierpaoli L, et al
    Patients with cancer and atrial fibrillation treated with doacs: A prospective cohort study.
    Int J Cardiol. 2018 Jul 29. pii: S0167-5273(18)32719.
    PubMed     Text format     Abstract available


  76. FUJIMOTO Y, Yodogawa K, Maru YJ, Oka E, et al
    Advanced interatrial block is an electrocardiographic marker for recurrence of atrial fibrillation after electrical cardioversion.
    Int J Cardiol. 2018 Jul 29. pii: S0167-5273(18)33748.
    PubMed     Text format     Abstract available


  77. MCALISTER FA, Wiebe N, Ronksley PE, Healey JS, et al
    Although non-stroke outcomes are more common, stroke risk scores can be used for prediction in patients with atrial fibrillation.
    Int J Cardiol. 2018 Jul 27. pii: S0167-5273(18)33059.
    PubMed     Text format     Abstract available


  78. LINZ D, Kadhim K, Brooks AG, Elliott AD, et al
    Diagnostic accuracy of overnight oximetry for the diagnosis of sleep-disordered breathing in atrial fibrillation patients.
    Int J Cardiol. 2018 Jul 25. pii: S0167-5273(18)32387.
    PubMed     Text format     Abstract available


  79. MUJOVIC N, Potpara TS
    Predicting incident atrial fibrillation in patients with diabetes mellitus.
    Int J Cardiol. 2018 Jul 25. pii: S0167-5273(18)34293.
    PubMed     Text format    


  80. O'BRIEN EC, Holmes DN, Thomas L, Singer DE, et al
    Incremental prognostic value of renal function for stroke prediction in atrial fibrillation.
    Int J Cardiol. 2018 Jul 25. pii: S0167-5273(18)31273.
    PubMed     Text format     Abstract available


  81. MIYAZAWA K, Li YG, Rashed WA, Al Mahmeed W, et al
    Secondary stroke prevention and guideline adherent antithrombotic treatment in patients with atrial fibrillation: Insights from the Gulf Survey of atrial fibrillation events (Gulf SAFE).
    Int J Cardiol. 2018 Jul 24. pii: S0167-5273(18)33607.
    PubMed     Text format     Abstract available


  82. BASKAR S, Veldtman GR, Khoury PR, Opotowsky AR, et al
    Characteristics of hospital admissions associated with implantable cardioverter defibrillator placement among adults with congenital heart disease.
    Int J Cardiol. 2018 Jul 24. pii: S0167-5273(18)32840.
    PubMed     Text format     Abstract available


  83. SMITH ED, Tome J, Mcgrath R, Kumar S, et al
    Exercise hemodynamics in hypertrophic cardiomyopathy identify risk of incident heart failure but not ventricular arrhythmias or sudden cardiac death.
    Int J Cardiol. 2018 Jul 24. pii: S0167-5273(18)33053.
    PubMed     Text format     Abstract available


  84. WANDELL P, Carlsson AC, Sundquist J, Sundquist K, et al
    Antihypertensive drugs and relevant cardiovascular pharmacotherapies and the risk of incident dementia in patients with atrial fibrillation.
    Int J Cardiol. 2018 Jul 21. pii: S0167-5273(18)32760.
    PubMed     Text format     Abstract available


  85. ARRIGO M, Feliot E, Gayat E, Mebazaa A, et al
    Cardiovascular events after ICU discharge in patients with new-onset atrial fibrillation: A report from the FROG-ICU study.
    Int J Cardiol. 2018 Jul 20. pii: S0167-5273(18)34103.
    PubMed     Text format    


  86. STABILE G, Tondo C, Curnis A, Lunati M, et al
    Efficacy of cryoballoon ablation in patients with paroxysmal atrial fibrillation without time to pulmonary vein isolation assessment.
    Int J Cardiol. 2018 Jul 20. pii: S0167-5273(18)32170.
    PubMed     Text format     Abstract available


  87. WANG XH, Li Z, Mao JL, Zang MH, et al
    Low voltage areas in paroxysmal atrial fibrillation: The prevalence, risk factors and impact on the effectiveness of catheter ablation.
    Int J Cardiol. 2018 Jul 19. pii: S0167-5273(18)33797.
    PubMed     Text format     Abstract available


  88. LANDOLINA M, Arena G, Iacopino S, Verlato R, et al
    Center experience does not influence long-term outcome and peri-procedural complications after cryoballoon ablation of paroxysmal atrial fibrillation: Data on 860 patients from the real-world multicenter observational project.
    Int J Cardiol. 2018 Jul 18. pii: S0167-5273(18)30400.
    PubMed     Text format     Abstract available


  89. DESTEGHE L, Germeys J, Vijgen J, Koopman P, et al
    Effectiveness and usability of an online tailored education platform for atrial fibrillation patients undergoing a direct current cardioversion or pulmonary vein isolation.
    Int J Cardiol. 2018 Jul 17. pii: S0167-5273(18)33446.
    PubMed     Text format     Abstract available


  90. GAIBAZZI N, Siniscalchi C, Reverberi C
    The Heart Sentinel app for detection and automatic alerting in cardiac arrest during outdoor sports: Field tests and ventricular fibrillation simulation results.
    Int J Cardiol. 2018 Jul 16. pii: S0167-5273(18)33416.
    PubMed     Text format    


  91. CAPUTO ML, van Stipdonk A, Illner A, D'Ambrosio G, et al
    The definition of left bundle branch block influences the response to cardiac resynchronization therapy.
    Int J Cardiol. 2018 Jul 16. pii: S0167-5273(18)32495.
    PubMed     Text format     Abstract available


  92. SAEED S, Gerdts E
    Incremental prognostic value of left atrial function indices in the prediction of incident atrial fibrillation in patients with ST-elevation myocardial infarction.
    Int J Cardiol. 2018;263:7-8.
    PubMed     Text format    


  93. ODENING KE
    Another step towards a mechanism-based, subtype-specific therapy in long QT syndrome.
    Int J Cardiol. 2018;263:67-68.
    PubMed     Text format    


  94. MELE D, Luisi GA, Ferrari R
    Evaluation of left ventricular systolic function during atrial fibrillation: Is it reliable?
    Int J Cardiol. 2018;263:63-64.
    PubMed     Text format    


  95. DONS M, Jensen JS, Olsen FJ, de Knegt MC, et al
    Global longitudinal strain corrected by RR-interval is a superior echocardiographic predictor of outcome in patients with atrial fibrillation.
    Int J Cardiol. 2018;263:42-47.
    PubMed     Text format     Abstract available


  96. MODIN D, Olsen FJ, Pedersen S, Jensen JS, et al
    Measures of left atrial function predict incident atrial fibrillation in STEMI patients treated with primary percutaneous coronary intervention.
    Int J Cardiol. 2018;263:1-6.
    PubMed     Text format     Abstract available


  97. BORIANI G, Proietti M, Laroche C, Diemberger I, et al
    Changes to oral anticoagulant therapy and risk of death over a 3-year follow-up of a contemporary cohort of European patients with atrial fibrillation final report of the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) pilot gener
    Int J Cardiol. 2018 Jul 9. pii: S0167-5273(17)38059.
    PubMed     Text format     Abstract available


  98. ZIUPA D, Menza M, Koppermann S, Moss R, et al
    Electro-mechanical (dys-)function in long QT syndrome type 1.
    Int J Cardiol. 2018 Jul 9. pii: S0167-5273(18)31662.
    PubMed     Text format     Abstract available


  99. MARZONA I, Proietti M, Farcomeni A, Romiti GF, et al
    Sex differences in stroke and major adverse clinical events in patients with atrial fibrillation: A systematic review and meta-analysis of 993,600 patients.
    Int J Cardiol. 2018 Jul 9. pii: S0167-5273(18)33433.
    PubMed     Text format     Abstract available


  100. SAKHI R, Yap SC, Michels M, Schinkel AFL, et al
    Evaluation of a novel automatic screening tool for determining eligibility for a subcutaneous implantable cardioverter-defibrillator.
    Int J Cardiol. 2018 Jul 6. pii: S0167-5273(18)33603.
    PubMed     Text format     Abstract available


  101. KHEIRI B, Osman M, Abdalla A, Haykal T, et al
    Catheter ablation of atrial fibrillation with heart failure: An updated meta-analysis of randomized trials.
    Int J Cardiol. 2018 Jul 4. pii: S0167-5273(18)32169.
    PubMed     Text format     Abstract available


  102. PROIETTI M
    Evolving concepts in atrial fibrillation epidemiology: Advancing knowledge about cardiovascular health in sub-Saharan Africa.
    Int J Cardiol. 2018 Jul 4. pii: S0167-5273(18)33362.
    PubMed     Text format    


  103. HU WS, Hsieh MH, Lin CL
    Comparisons of changes in the adapted diabetes complications severity index and CHA2DS2-VASc score for atrial fibrillation risk stratification in patients with type 2 diabetes mellitus: A nationwide cohort study.
    Int J Cardiol. 2018 Jul 3. pii: S0167-5273(18)32963.
    PubMed     Text format     Abstract available


  104. PROTONOTARIOS A, Elliott PM
    Arrhythmogenic right ventricular cardiomyopathy as a hidden cause of paediatric myocarditis presentation.
    Int J Cardiol. 2018 Jul 2. pii: S0167-5273(18)33478.
    PubMed     Text format    


  105. BURLACU A, Covic A
    'Some doors are better left closed': Using LAA occluders as an alternative to warfarin in very high-risk dialysed patients with atrial fibrillation.
    Int J Cardiol. 2018;262:43-44.
    PubMed     Text format    


    June 2018
  106. COHEN AT, Hill NR, Luo X, Masseria C, et al
    A systematic review of network meta-analyses among patients with nonvalvular atrial fibrillation: A comparison of efficacy and safety following treatment with direct oral anticoagulants.
    Int J Cardiol. 2018 Jun 30. pii: S0167-5273(17)37924.
    PubMed     Text format     Abstract available


  107. WENG CJ, Li CH, Liao YC, Lin CC, et al
    Rhythm control better prevents stroke and mortality than rate control strategies in patients with atrial fibrillation - A nationwide cohort study.
    Int J Cardiol. 2018 Jun 26. pii: S0167-5273(18)33463.
    PubMed     Text format     Abstract available


  108. AYABE K, Goto S
    High rate of death in patients with atrial fibrillation -Results from EORP-AF Pilot General Registry.
    Int J Cardiol. 2018 Jun 22. pii: S0167-5273(18)33076.
    PubMed     Text format    


  109. TOSO E, Peyracchia M, Matta M, D'Ascenzo F, et al
    Incidence of thromboembolic events following atrial fibrillation catheter ablation and rate control strategies according to the kind of oral anticoagulation: A systematic review and meta-analysis.
    Int J Cardiol. 2018 Jun 19. pii: S0167-5273(18)30865.
    PubMed     Text format     Abstract available


  110. ANDERSSON NW, Svanstrom H, Lund M, Pasternak B, et al
    Comparative effectiveness and safety of apixaban, dabigatran, and rivaroxaban in patients with non-valvular atrial fibrillation.
    Int J Cardiol. 2018 Jun 19. pii: S0167-5273(17)35612.
    PubMed     Text format     Abstract available


  111. SPOSATO LA, Lopes RD
    Disentangling the risk of atrial fibrillation detected after ischemic stroke (AFDAS): A real challenge in clinical practice.
    Int J Cardiol. 2018;261:99-100.
    PubMed     Text format    


  112. LI Y, Pastori D, Guo Y, Wang Y, et al
    Risk factors for new-onset atrial fibrillation: A focus on Asian populations.
    Int J Cardiol. 2018;261:92-98.
    PubMed     Text format     Abstract available


  113. HSIEH CY, Lee CH, Wu DP, Sung SF, et al
    Characteristics and outcomes of ischemic stroke in patients with known atrial fibrillation or atrial fibrillation diagnosed after stroke.
    Int J Cardiol. 2018;261:68-72.
    PubMed     Text format     Abstract available


  114. CHAO TF, Chen SA
    What to do when patients having a high risk of new-onset atrial fibrillation are identified?
    Int J Cardiol. 2018;261:101-102.
    PubMed     Text format    


  115. FENDER AC, Dobrev D
    Switching off the jitters: Dabigatran as a candidate approach to halt atrial fibrillation?
    Int J Cardiol. 2018 Jun 13. pii: S0167-5273(18)33661.
    PubMed     Text format    


  116. GOETTE A
    Uninterrupted NOAC therapy in patients undergoing catheter ablation of atrial fibrillation: "Dual anticoagulant therapy" ready for primetime or systematic overtreatment?
    Int J Cardiol. 2018 Jun 13. pii: S0167-5273(18)33663.
    PubMed     Text format    


  117. ZHAO Y, Lu Y, Qin Y
    A meta-analysis of randomized controlled trials of uninterrupted periprocedural anticoagulation strategy in patients undergoing atrial fibrillation catheter ablation.
    Int J Cardiol. 2018 Jun 8. pii: S0167-5273(18)32747.
    PubMed     Text format     Abstract available


  118. TRAN HV, Erskine NA, Nguyen HL, McManus DD, et al
    Increase in white blood cell count is associated with the development of atrial fibrillation after an acute coronary syndrome.
    Int J Cardiol. 2018 Jun 5. pii: S0167-5273(17)37883.
    PubMed     Text format     Abstract available


  119. WANG X, Fu Q, Song F, Li W, et al
    Prevalence of atrial fibrillation in different socioeconomic regions of China and its association with stroke: Results from a national stroke screening survey.
    Int J Cardiol. 2018 Jun 2. pii: S0167-5273(18)30996.
    PubMed     Text format     Abstract available


  120. KOHNO T, Kimura T, Fukunaga K, Yamasawa W, et al
    Prevalence and clinical characteristics of obstructive- and central-dominant sleep apnea in candidates of catheter ablation for atrial fibrillation in Japan.
    Int J Cardiol. 2018;260:99-102.
    PubMed     Text format     Abstract available


  121. TSE G, Liu T, Baranchuk A
    Authors' reply: Low prevalence of inter-atrial block in the general population from China: A possible reason for its low rates of atrial fibrillation.
    Int J Cardiol. 2018;260:112.
    PubMed     Text format    


  122. SUN GZ, Wang HY, Zhou Y, Sun YX, et al
    Low prevalence of inter-atrial block in the general population from China: A possible reason for its low rates of atrial fibrillation.
    Int J Cardiol. 2018;260:111.
    PubMed     Text format    


  123. SHIZUTA S, Kawaji T, Kimura T
    Reply to "Should we isolate superior vena cava and to ablate cavo-tricuspid isthmus in all patients with atrial fibrillation during pulmtonary vein isolation?"
    Int J Cardiol. 2018;260:110.
    PubMed     Text format    


  124. ORCZYKOWSKI M, Szumowski L
    Should we isolate superior vena cava and to ablate cavo-tricuspid isthmus in all patients with atrial fibrillation during pulmonary vein isolation?
    Int J Cardiol. 2018;260:109.
    PubMed     Text format    


  125. LINZ D, Nalliah C, Kalman J, Sanders P, et al
    Routine screening for sleep apnea in patients with atrial fibrillation: Ready for primetime?
    Int J Cardiol. 2018;260:103-104.
    PubMed     Text format    


  126. CONTE G, Soejima K, de Asmundis C, Chierchia GB, et al
    Value of high-resolution mapping in optimizing cryoballoon ablation of atrial fibrillation.
    Int J Cardiol. 2018 Jun 1. pii: S0167-5273(18)30713.
    PubMed     Text format     Abstract available


  127. RICCIARDI G, Checchi L
    Permanent his bundle pacing: A physiological alternative to conventional right ventricular pacing or just a futile artifice?
    Int J Cardiol. 2018;260:107-108.
    PubMed     Text format    


    May 2018
  128. MARTINS D, Ovaert C, Khraiche D, Boddaert N, et al
    Myocardial inflammation detected by cardiac MRI in Arrhythmogenic right ventricular cardiomyopathy: A paediatric case series.
    Int J Cardiol. 2018 May 31. pii: S0167-5273(18)31054.
    PubMed     Text format     Abstract available


  129. CHELU MG, Li N
    Biomarkers (plasma trimethylamine-N-oxide) to predict atrial fibrillation: Are we there yet?
    Int J Cardiol. 2018 May 30. pii: S0167-5273(18)32813.
    PubMed     Text format    


  130. CARMO AAL, de Sousa MR, Agudelo JF, Boersma E, et al
    Implantable cardioverter-defibrillator in Chagas heart disease: A systematic review and meta-analysis of observational studies.
    Int J Cardiol. 2018 May 29. pii: S0167-5273(18)30210.
    PubMed     Text format     Abstract available


  131. BEN-DOV N, Newman D, Crystal E
    Robotic magnetic catheter navigation as a first step in the automation of the ablation procedures for ventricular arrhythmia.
    Int J Cardiol. 2018 May 26. pii: S0167-5273(18)33283.
    PubMed     Text format    


  132. MUTHALALY RG, Koplan BA, Albano A, North C, et al
    Low population prevalence of atrial fibrillation in rural Uganda: A community-based cross-sectional study.
    Int J Cardiol. 2018 May 24. pii: S0167-5273(18)31107.
    PubMed     Text format     Abstract available


  133. SHULMAN E, Shah T, Mazori AY, Chudow JJ, et al
    Heart failure and the development of atrial fibrillation in Hispanics, African Americans and non-Hispanic Whites.
    Int J Cardiol. 2018 May 22. pii: S0167-5273(17)37213.
    PubMed     Text format    


  134. FENDER AC, Dobrev D
    The not-so-sweet problem of hearts aflutter: Dissecting stroke risk in atrial fibrillation with concomitant diabetes.
    Int J Cardiol. 2018 May 19. pii: S0167-5273(18)33126.
    PubMed     Text format    


  135. ESCOBAR-ROBLEDO LA, Bayes-de-Luna A, Lupon J, Baranchuk A, et al
    Advanced interatrial block predicts new-onset atrial fibrillation and ischemic stroke in patients with heart failure: The "Bayes' Syndrome-HF" study.
    Int J Cardiol. 2018 May 18. pii: S0167-5273(18)31019.
    PubMed     Text format     Abstract available


  136. MESQUITA J, Ferreira AM, Cavaco D, Carmo P, et al
    Impact of prophylactic cavotricuspid isthmus ablation in atrial fibrillation recurrence after a first pulmonary vein isolation procedure.
    Int J Cardiol. 2018;259:82-87.
    PubMed     Text format     Abstract available


  137. AKKAYA E, Berkowitsch A, Zaltsberg S, Greiss H, et al
    Second-generation cryoballoon ablation as a first-line treatment of symptomatic atrial fibrillation: Two-year outcome and predictors of recurrence after a single procedure.
    Int J Cardiol. 2018;259:76-81.
    PubMed     Text format     Abstract available


  138. ROMERO J, Di Biase L
    Empirical cavotricuspid isthmus line for atrial fibrillation ablation is futile "Repetita Iuvant".
    Int J Cardiol. 2018;259:107-108.
    PubMed     Text format    


  139. KOSIUK J, de Potter T, Linz D
    The role of electroanatomical mapping in individualized treatment of paroxysmal atrial fibrillation.
    Int J Cardiol. 2018;259:105-106.
    PubMed     Text format    


  140. YASUDA S, Kaikita K, Ogawa H, Akao M, et al
    Atrial fibrillation and ischemic events with rivaroxaban in patients with stable coronary artery disease (AFIRE): Protocol for a multicenter, prospective, randomized, open-label, parallel group study.
    Int J Cardiol. 2018 May 2. pii: S0167-5273(17)36755.
    PubMed     Text format     Abstract available


  141. TSATSOPOULOU A
    Arrhythmogenic right ventricular cardiomyopathy and pregnancy.
    Int J Cardiol. 2018;258:199-200.
    PubMed     Text format    


  142. GANDJBAKHCH E, Varlet E, Duthoit G, Fressart V, et al
    Pregnancy and newborn outcomes in arrhythmogenic right ventricular cardiomyopathy/dysplasia.
    Int J Cardiol. 2018;258:172-178.
    PubMed     Text format     Abstract available


  143. ABUBAKAR H, Osman M, Akintoye E, Subahi A, et al
    Intra-thoracic Impedance and the Onset of Atrial and Ventricular Tachyarrhythmias: A Meta-analysis.
    Int J Cardiol. 2018;258:144-150.
    PubMed     Text format     Abstract available


  144. WANG L, Bi Y, Yu M, Li T, et al
    Phosphatidylserine-exposing blood cells and microparticles induce procoagulant activity in non-valvular atrial fibrillation.
    Int J Cardiol. 2018;258:138-143.
    PubMed     Text format     Abstract available


  145. BOVEDA S, Chalbia TE, Jacob S, Combes S, et al
    Duration of hospital admission, need of on-demand analgesia and other peri-procedural and short-term outcomes in sub-cutaneous vs. transvenous implantable cardioverter-defibrillators.
    Int J Cardiol. 2018;258:133-137.
    PubMed     Text format     Abstract available


  146. SANTORO F, Stiermaier T, Tarantino N, Guastafierro F, et al
    Diagnostic criteria, left ventricular thrombosis, and QT-interval in Takotsubo syndrome.
    Int J Cardiol. 2018;258:29.
    PubMed     Text format    


  147. BOERSMA LVA
    Optimizing S-ICD implant technique: No pain, the true gain?
    Int J Cardiol. 2018;258:159-160.
    PubMed     Text format    


    April 2018
  148. AMIN AS, Reckman YJ, Arbelo E, Spanjaart AM, et al
    SCN5A mutation type and topology are associated with the risk of ventricular arrhythmia by sodium channel blockers.
    Int J Cardiol. 2018 Apr 27. pii: S0167-5273(17)32831.
    PubMed     Text format     Abstract available


  149. ZOPPELLARO G, Zanella L, Denas G, Gennaro N, et al
    Different safety profiles of oral anticoagulants in very elderly non-valvular atrial fibrillation patients. A retrospective propensity score matched cohort study.
    Int J Cardiol. 2018 Apr 25. pii: S0167-5273(18)30527.
    PubMed     Text format    


  150. LUO J, Li H, Qin X, Liu B, et al
    Increased risk of ischemic stroke associated with new-onset atrial fibrillation complicating acute coronary syndrome: A systematic review and meta-analysis.
    Int J Cardiol. 2018 Apr 23. pii: S0167-5273(17)37900.
    PubMed     Text format     Abstract available


  151. SILLER-MATULA JM, Pecen L, Patti G, Lucerna M, et al
    Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF - HF substudy.
    Int J Cardiol. 2018 Apr 22. pii: S0167-5273(17)37365.
    PubMed     Text format     Abstract available


  152. MASUDA M, Fujita M, Iida O, Okamoto S, et al
    Left atrial low-voltage areas predict atrial fibrillation recurrence after catheter ablation in patients with paroxysmal atrial fibrillation.
    Int J Cardiol. 2018;257:97-101.
    PubMed     Text format     Abstract available


  153. DE POOTER J, Kamoen V, El Haddad M, Stroobandt R, et al
    Gender differences in electro-mechanical characteristics of left bundle branch block: Potential implications for selection and response of cardiac resynchronization therapy.
    Int J Cardiol. 2018;257:84-91.
    PubMed     Text format     Abstract available


  154. BARNETT AS, Cyr DD, Goodman SG, Levitan BS, et al
    Net clinical benefit of rivaroxaban compared with warfarin in atrial fibrillation: Results from ROCKET AF.
    Int J Cardiol. 2018;257:78-83.
    PubMed     Text format     Abstract available


  155. TSATSOPOULOU A, Bossone E
    Common presentation of rare diseases: Arrhythmogenic right ventricular cardiomyopathy and its mimics.
    Int J Cardiol. 2018;257:371-377.
    PubMed     Text format     Abstract available


  156. MANSORI K, Ayubi E
    Comments on association of sST2 and hs-CRP levels with new-onset atrial fibrillation in coronary artery disease.
    Int J Cardiol. 2018;257:32.
    PubMed     Text format    


  157. GOUDIS CA, Vasileiadis IE, Liu T
    CHA2DS2-VASc: An eligible score for atrial fibrillation prediction in chronic obstructive pulmonary disease?
    Int J Cardiol. 2018;257:299.
    PubMed     Text format    


  158. KHAZAEI S, Karami M, Veisani Y
    Comment on "Alcohol and incident atrial fibrillation-A systematic review and meta-analysis".
    Int J Cardiol. 2018;257:117.
    PubMed     Text format    


  159. AYUBI E, Safiri S
    Comments on clinical predictors of challenging atrioventricular node ablation procedure for rate control in patients with atrial fibrillation.
    Int J Cardiol. 2018;257:116.
    PubMed     Text format    


  160. AZADANI PN, Marrouche NF, Wilson BD
    Left atrial fibrosis provides a new means of identifying patients with higher risk of new-onset heart failure among patients with atrial fibrillation.
    Int J Cardiol. 2018;257:113-114.
    PubMed     Text format    


  161. DENG Y, Qin F, Liu Q, Wu Z, et al
    Left atrial fibrosis provides a new means of identifying patients with higher risk of new-onset heart failure among patients with atrial fibrillation.
    Int J Cardiol. 2018;257:110.
    PubMed     Text format    


  162. SANTORO F, Stiermaier T, Tarantino N, Guastafierro F, et al
    ST-elevation magnitude and evolution in Takotsubo syndrome.
    Int J Cardiol. 2018;257:39.
    PubMed     Text format    


  163. BAI J, Shen D, Wang B, Han Q, et al
    Could the CHA2DS2-VASc schema help stratify risk of ischemic stroke for individual patients with congestive heart failure?
    Int J Cardiol. 2018;257:226.
    PubMed     Text format    


  164. BRAILLON A
    Torsade de Pointes: The tip of the iceberg.
    Int J Cardiol. 2018;257:115.
    PubMed     Text format    


  165. WYLIE J
    Letter to the Editor RE: Incidence of Torsade de Pointes in a tertiary hospital population by Vandael et al.
    Int J Cardiol. 2018;257:111.
    PubMed     Text format    


  166. LI B, Sun C, Qin F, Liu N, et al
    Could direct oral anticoagulants be an alternative to vitamin K antagonists in patients with hypertrophic cardiomyopathy and atrial fibrillation?
    Int J Cardiol. 2018;256:39.
    PubMed     Text format    


  167. SUN C, Wang W, Leng T, Shi Y, et al
    Letter regarding Nakamura et al. "Anatomical relationship of coronary sinus/great cardiac vein and left circumflex coronary artery along mitral annulus in atrial fibrillation before radiofrequency catheter ablation using 320-slice CT".
    Int J Cardiol. 2018;256:26.
    PubMed     Text format    


  168. SANCHIS-GOMAR F, Lippi G, Cervellin G, Perez-Quilis C, et al
    PAFIYAMA syndrome evidence in highly trained population.
    Int J Cardiol. 2018;256:10.
    PubMed     Text format    


  169. BRUNETTI ND, Tarantino N, Santoro F, Correale M, et al
    "PAFIYAMA" syndrome; further evidence on a novel clinical entity.
    Int J Cardiol. 2018;256:9.
    PubMed     Text format    


  170. BANDYOPADHYAY D, Ashish K, Hajra A, Ghosh RK, et al
    An interesting insight into breakfast and cardiovascular disease.
    Int J Cardiol. 2018;256:7.
    PubMed     Text format    


    March 2018
  171. HAHAD O, Beutel M, Gori T, Schulz A, et al
    Annoyance to different noise sources is associated with atrial fibrillation in the Gutenberg Health Study.
    Int J Cardiol. 2018 Mar 29. pii: S0167-5273(17)37174.
    PubMed     Text format     Abstract available


  172. HA FJ, Barra S, Brown AJ, Begley DB, et al
    Continuous and minimally-interrupted direct oral anticoagulant are both safe compared with vitamin K antagonist for atrial fibrillation ablation: An updated meta-analysis.
    Int J Cardiol. 2018 Mar 21. pii: S0167-5273(18)31037.
    PubMed     Text format     Abstract available


  173. YU L, Meng G, Huang B, Zhou X, et al
    A potential relationship between gut microbes and atrial fibrillation: Trimethylamine N-oxide, a gut microbe-derived metabolite, facilitates the progression of atrial fibrillation.
    Int J Cardiol. 2018;255:92-98.
    PubMed     Text format     Abstract available


  174. MISHIMA RS, Elliott AD, Sanders P, Linz D, et al
    Microbiome and atrial fibrillation.
    Int J Cardiol. 2018;255:103-104.
    PubMed     Text format    


  175. TSUJI Y, Dobrev D
    Prognostic impact of electrical storm in patients with implantable cardioverter defibrillators: Mechanistic and therapeutic considerations to reduce the risk of death.
    Int J Cardiol. 2018;255:101-102.
    PubMed     Text format    


  176. EICKHOLT C
    Finding the right timing in cryoballoon ablation for pulmonary vein isolation.
    Int J Cardiol. 2018;255:99-100.
    PubMed     Text format    


  177. NODA T, Kurita T, Nitta T, Chiba Y, et al
    Significant impact of electrical storm on mortality in patients with structural heart disease and an implantable cardiac defibrillator.
    Int J Cardiol. 2018;255:85-91.
    PubMed     Text format     Abstract available


  178. POTT A, Kraft C, Stephan T, Petscher K, et al
    Time-to-isolation guided titration of freeze duration in 3rd generation short-tip cryoballoon pulmonary vein isolation - Comparable clinical outcome and shorter procedure duration.
    Int J Cardiol. 2018;255:80-84.
    PubMed     Text format     Abstract available


  179. LEE HF, Chan YH, Tu HT, Kuo CT, et al
    The effectiveness and safety of low-dose rivaroxaban in Asians with non-valvular atrial fibrillation.
    Int J Cardiol. 2018 Mar 14. pii: S0167-5273(17)37808.
    PubMed     Text format     Abstract available


  180. DIEMBERGER I, Fantecchi E, Reggiani MLB, Martignani C, et al
    Atrial fibrillation and prediction of mortality by conventional clinical score systems according to the setting of care.
    Int J Cardiol. 2018 Mar 14. pii: S0167-5273(17)38078.
    PubMed     Text format     Abstract available


  181. PROIETTI M, Romiti GF, Romanazzi I, Farcomeni A, et al
    Restarting oral anticoagulant therapy after major bleeding in atrial fibrillation: A systematic review and meta-analysis.
    Int J Cardiol. 2018 Mar 14. pii: S0167-5273(18)31060.
    PubMed     Text format     Abstract available


  182. BISSON A, Bodin A, Clementy N, Bernard A, et al
    Stroke, thromboembolism and bleeding in patients with atrial fibrillation according to the EHRA valvular heart disease classification.
    Int J Cardiol. 2018 Mar 7. pii: S0167-5273(18)30084.
    PubMed     Text format     Abstract available


  183. KAWADA T
    Periodic limb movements of sleep and atrial fibrillation in patients with mild sleep-disordered breathing.
    Int J Cardiol. 2018;254:345.
    PubMed     Text format    


  184. YALTA K, Taylan G, Gurlertop Y
    Atrial fibrillation in the setting of takotsubo cardiomyopathy: Just the tip of the iceberg?
    Int J Cardiol. 2018;254:174.
    PubMed     Text format    


  185. PROIETTI M
    The dangerous combination of atrial fibrillation and hypertension: An urgent need to handle complexity.
    Int J Cardiol. 2018;254:167-169.
    PubMed     Text format    


  186. MUJOVIC N, Potpara TS
    Optimizing bleeding risk assessment in patients with atrial fibrillation: To score or not to score?
    Int J Cardiol. 2018;254:164-166.
    PubMed     Text format    


  187. CHAO TF, Lip GYH, Lin YJ, Chang SL, et al
    Major bleeding and intracranial hemorrhage risk prediction in patients with atrial fibrillation: Attention to modifiable bleeding risk factors or use of a bleeding risk stratification score? A nationwide cohort study.
    Int J Cardiol. 2018;254:157-161.
    PubMed     Text format     Abstract available


  188. DAN GA, Badila E, Weiss E, Laroche C, et al
    Arterial hypertension in patients with atrial fibrillation in Europe: A report from the EURObservational Research Programme pilot survey on atrial fibrillation.
    Int J Cardiol. 2018;254:136-141.
    PubMed     Text format     Abstract available


  189. POPPE KK, Doughty RN, Harwood M, Barber PA, et al
    Identification, risk assessment, and management of patients with atrial fibrillation in a large primary care cohort.
    Int J Cardiol. 2018;254:119-124.
    PubMed     Text format     Abstract available


  190. SANTORO F, Di Biase M, Brunetti ND
    Effect of sex hormones in Takotsubo cardiomyopathy: Just matter of arrhythmias or also outcomes?
    Int J Cardiol. 2018;254:246-247.
    PubMed     Text format    


  191. GIUSTETTO C, Cerrato N, Gaita F
    Drug-induced type 1 Brugada ECG: Lights and shadows.
    Int J Cardiol. 2018;254:170-171.
    PubMed     Text format    


  192. DE LAZZARI M, Perazzolo Marra M
    The myocardial bright signal: The arrhythmogenic link between function and myocardial fibrosis.
    Int J Cardiol. 2018;254:258-259.
    PubMed     Text format    


  193. EL-BATTRAWY I, Zhao Z, Lan H, Schunemann JD, et al
    Estradiol protection against toxic effects of catecholamine on electrical properties in human-induced pluripotent stem cell derived cardiomyocytes.
    Int J Cardiol. 2018;254:195-202.
    PubMed     Text format     Abstract available


  194. GATZOULIS KA, Georgopoulos S, Antoniou CK, Anastasakis A, et al
    Programmed ventricular stimulation predicts arrhythmic events and survival in hypertrophic cardiomyopathy.
    Int J Cardiol. 2018;254:175-181.
    PubMed     Text format     Abstract available


  195. SHI S, Barajas-Martinez H, Liu T, Sun Y, et al
    Prevalence of spontaneous Brugada ECG pattern recorded at standard intercostal leads: A meta-analysis.
    Int J Cardiol. 2018;254:151-156.
    PubMed     Text format     Abstract available


  196. DELISE P, Allocca G, Sitta N, Migliore F, et al
    Cardiac arrest and Brugada syndrome: Is drug-induced type 1 ECG pattern always a marker of low risk?
    Int J Cardiol. 2018;254:142-145.
    PubMed     Text format     Abstract available


    February 2018
  197. TENMA T, Yokoshiki H, Mitsuyama H, Watanabe M, et al
    Relation between total shock energy and mortality in patients with implantable cardioverter-defibrillator.
    Int J Cardiol. 2018 Feb 20. pii: S0167-5273(17)37446.
    PubMed     Text format     Abstract available


  198. GOETTE A
    Atrial fibrillation and stroke risk factors induce decline in creatinine clearance: Is there a specific "fibrillatory kidney disease"?
    Int J Cardiol. 2018;253:82-83.
    PubMed     Text format    


  199. BEYER-WESTENDORF J, Kreutz R, Posch F, Ay C, et al
    The CHA2DS2-VASc score strongly correlates with glomerular filtration rate and predicts renal function decline over time in elderly patients with atrial fibrillation and chronic kidney disease.
    Int J Cardiol. 2018;253:71-77.
    PubMed     Text format     Abstract available


  200. CONTE G, Caputo ML, Volders PGA, Luca A, et al
    Concealed abnormal atrial phenotype in patients with Brugada syndrome and no history of atrial fibrillation.
    Int J Cardiol. 2018;253:66-70.
    PubMed     Text format     Abstract available


  201. NAMMAS W, Kiviniemi T, Schlitt A, Rubboli A, et al
    Value of DAPT score to predict adverse outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: A post-hoc analysis from the AFCAS registry.
    Int J Cardiol. 2018;253:35-39.
    PubMed     Text format     Abstract available


  202. FENDER AC
    PS. It was me all along! Emergence of phosphatidylserine in the procoagulant state in atrial fibrillation.
    Int J Cardiol. 2018 Feb 12. pii: S0167-5273(18)30663.
    PubMed     Text format    


  203. SHIMOKAWA H, Yamashita T, Uchiyama S, Kitazono T, et al
    The EXPAND study: Efficacy and safety of rivaroxaban in Japanese patients with non-valvular atrial fibrillation.
    Int J Cardiol. 2018 Feb 3. pii: S0167-5273(18)30592.
    PubMed     Text format     Abstract available


  204. BARI V, Ranucci M, De Maria B, Cairo B, et al
    Model-based directional analysis of cardiovascular variability identifies patients developing atrial fibrillation after coronary artery bypass grafting.
    Int J Cardiol. 2018 Feb 2. pii: S0167-5273(17)37276.
    PubMed     Text format     Abstract available


  205. LIU FZ, Liao HT, Lin WD, Xue YM, et al
    Predictive effect of hyperuricemia on left atrial stasis in non-valvular atrial fibrillation patients.
    Int J Cardiol. 2018 Feb 2. pii: S0167-5273(17)37479.
    PubMed     Text format     Abstract available


  206. PROIETTI M, Lip GYH
    Impact of quality of anticoagulation control on outcomes in patients with atrial fibrillation taking aspirin: An analysis from the SPORTIF trials.
    Int J Cardiol. 2018;252:96-100.
    PubMed     Text format     Abstract available


  207. CHUGH SS
    Heart failure and atrial fibrillation: Can we break this nexus?
    Int J Cardiol. 2018;252:142-143.
    PubMed     Text format    


  208. ZIFF OJ, Carter PR, McGowan J, Uppal H, et al
    The interplay between atrial fibrillation and heart failure on long-term mortality and length of stay: Insights from the, United Kingdom ACALM registry.
    Int J Cardiol. 2018;252:117-121.
    PubMed     Text format     Abstract available


  209. FAUCHIER L, Bisson A, Genet T
    Antiplatelet therapy, vitamin K antagonist and low time in therapeutic range in patients with atrial fibrillation: Highway to bleed.
    Int J Cardiol. 2018;252:110-111.
    PubMed     Text format    


  210. DRAGO F
    Postoperative arrhythmias after AVSD repair: The lack of regular periodic rhythm surveillance allows you to see only the tip of the iceberg.
    Int J Cardiol. 2018;252:94-95.
    PubMed     Text format    


  211. KHARBANDA RK, Blom NA, Hazekamp MG, Yildiz P, et al
    Incidence and risk factors of post-operative arrhythmias and sudden cardiac death after atrioventricular septal defect (AVSD) correction: Up to 47years of follow-up.
    Int J Cardiol. 2018;252:88-93.
    PubMed     Text format     Abstract available


  212. BRONZETTI G, Brighenti M, Mariucci E, Fabi M, et al
    Upside-down position for the out of hospital management of children with supraventricular tachycardia.
    Int J Cardiol. 2018;252:106-109.
    PubMed     Text format     Abstract available


    January 2018
  213. KAPA S, Vaidya V, Hodge DO, McLeod CJ, et al
    Right ventricular dysfunction in congenitally corrected transposition of the great arteries and risk of ventricular tachyarrhythmia and sudden death.
    Int J Cardiol. 2018 Jan 31. pii: S0167-5273(17)36055.
    PubMed     Text format     Abstract available


  214. TE ALD, Lo LW, Lin YJ, Chang SL, et al
    Vasovagal responses during cryoballoon pulmonary vein isolation in paroxysmal atrial fibrillation predict favorable mid-term outcomes.
    Int J Cardiol. 2018 Jan 31. pii: S0167-5273(17)36027.
    PubMed     Text format     Abstract available


  215. CAVALLARI I, Ruff CT, Nordio F, Deenadayalu N, et al
    Clinical events after interruption of anticoagulation in patients with atrial fibrillation: An analysis from the ENGAGE AF-TIMI 48 trial.
    Int J Cardiol. 2018 Jan 26. pii: S0167-5273(17)35262.
    PubMed     Text format     Abstract available


  216. JOLOBE OMP
    Proposed rationale for anticoagulants in nonvalvular atrial fibrillation with zero CHA2DS2-Vasc score.
    Int J Cardiol. 2018 Jan 21. pii: S0167-5273(17)36194.
    PubMed     Text format    


  217. EL-BATTRAWY I, Borggrefe M, Akin I
    Atrial fibrillation impacts the outcome in Takotsubo syndrome.
    Int J Cardiol. 2018;251:57.
    PubMed     Text format    


  218. GALLAGHER C, Hendriks JML, Lau DH, Sanders P, et al
    Alcohol and atrial fibrillation.
    Int J Cardiol. 2018;251:56.
    PubMed     Text format    


  219. YANG Y, Hu D, Peng D
    Should small-to-moderate alcohol consumption be recommended for healthy middle-aged women?
    Int J Cardiol. 2018;251:55.
    PubMed     Text format    


  220. PARREIRA L, Marinheiro R
    "Excessive" atrial ectopy is worse than "frequent" atrial ectopy.
    Int J Cardiol. 2018;251:54.
    PubMed     Text format    


  221. QIN F, Liu N, Liu C, Bai F, et al
    Could excessive atrial ectopic activity be an independent risk factor for ischemic stroke?
    Int J Cardiol. 2018;251:53.
    PubMed     Text format    


  222. BAI R
    Percutaneous left atrial appendage closure versus oral anticoagulant: A bird in the hand is worth two in the bush?
    Int J Cardiol. 2018;251:51-52.
    PubMed     Text format    


  223. FERLINI M, Rossini R
    Left atrial appendage closure: Six reasons why I wouldn't choose a percutaneous closure for my appendage.
    Int J Cardiol. 2018;251:42-44.
    PubMed     Text format     Abstract available


  224. KISS A, Podesser BK
    Low-dose of relaxin protects against arrhythmias and adverse left ventricle remodeling.
    Int J Cardiol. 2018;250:60-61.
    PubMed     Text format    


  225. BEIERT T, Knappe V, Tiyerili V, Stockigt F, et al
    Chronic lower-dose relaxin administration protects from arrhythmia in experimental myocardial infarction due to anti-inflammatory and anti-fibrotic properties.
    Int J Cardiol. 2018;250:21-28.
    PubMed     Text format     Abstract available


    December 2017
  226. PASTORI D, Pignatelli P, Sciacqua A, Perticone M, et al
    Relationship of peripheral and coronary artery disease to cardiovascular events in patients with atrial fibrillation.
    Int J Cardiol. 2017 Dec 24. pii: S0167-5273(17)36573.
    PubMed     Text format     Abstract available


  227. HEIJMAN J, Kirchner D, Kunze F, Chretien EM, et al
    Muscarinic type-1 receptors contribute to IK,ACh in human atrial cardiomyocytes and are upregulated in patients with chronic atrial fibrillation.
    Int J Cardiol. 2017 Dec 22. pii: S0167-5273(17)37262.
    PubMed     Text format     Abstract available


  228. ANTZELEVITCH C, Di Diego JM, Argenziano M
    Tpeak-Tend as a predictor of ventricular arrhythmogenesis.
    Int J Cardiol. 2017;249:75-76.
    PubMed     Text format    


  229. WONG CX
    Atrial fibrillation, hip fracture, and oral anticoagulation therapy.
    Int J Cardiol. 2017;249:260.
    PubMed     Text format    


  230. CERIT L
    Atrial fibrillation, hip fracture, and oral anticoagulant therapy.
    Int J Cardiol. 2017;249:259.
    PubMed     Text format    


  231. SPARTALIS M, Tzatzaki E, Dimitroulis D, Spartalis E, et al
    The emerging role of hybrid ablation for atrial fibrillation.
    Int J Cardiol. 2017;249:257.
    PubMed     Text format    


  232. BERTAGLIA E, Anselmino M, Zorzi A, Russo V, et al
    NOACs and atrial fibrillation: Incidence and predictors of left atrial thrombus in the real world.
    Int J Cardiol. 2017;249:179-183.
    PubMed     Text format     Abstract available


  233. DING M, Fratiglioni L, Johnell K, Fastbom J, et al
    Atrial fibrillation and use of antithrombotic medications in older people: A population-based study.
    Int J Cardiol. 2017;249:173-178.
    PubMed     Text format     Abstract available


  234. CHIU SN, Huang SC, Wang JK, Lu CW, et al
    Implantable cardioverter defibrillator therapy in repaired tetralogy of Fallot after pulmonary valve replacement: Implications for the mechanism of ventricular arrhythmia.
    Int J Cardiol. 2017;249:156-160.
    PubMed     Text format     Abstract available


  235. TSATSOPOULOU A
    Desmoplakin: Highlights on a left ventricular arrhythmogenic disorder.
    Int J Cardiol. 2017;249:324-325.
    PubMed     Text format    


  236. WAKILI R, Dobrev D
    Response to: "The emerging role of hybrid ablation for ablation" by Spartialis M. et al.
    Int J Cardiol. 2017;249:258.
    PubMed     Text format    


  237. GOETTE A
    Why is there still undertreatment with oral anticoagulants in elderly high risk patients with AF?
    Int J Cardiol. 2017;249:247-248.
    PubMed     Text format    


  238. ESTEVE-PASTOR MA, Rivera-Caravaca JM, Roldan V, Vicente V, et al
    Estimated absolute effects on efficacy and safety outcomes of using non-vitamin K antagonist oral anticoagulants in 'real-world' atrial fibrillation patients: A comparison with optimally acenocoumarol anticoagulated patients.
    Int J Cardiol. 2017 Dec 14. pii: S0167-5273(17)34423.
    PubMed     Text format     Abstract available


  239. BUIATTI A, von Olshausen G, Martens E, Schinke K, et al
    Balloon angioplasty versus stenting for pulmonary vein stenosis after pulmonary vein isolation for atrial fibrillation: A meta-analysis.
    Int J Cardiol. 2017 Dec 6. pii: S0167-5273(17)35398.
    PubMed     Text format     Abstract available


  240. LIEDER H, Breithardt G, Heusch G
    Fatal attraction - A brief pathophysiology of the interaction between atrial fibrillation and myocardial ischemia.
    Int J Cardiol. 2017 Dec 6. pii: S0167-5273(17)36897.
    PubMed     Text format     Abstract available


  241. LINZ D, Elliott AD, Marwick TH, Sanders P, et al
    Biomarkers and new-onset atrial fibrillation to assess atrial cardiomyopathy.
    Int J Cardiol. 2017;248:208-210.
    PubMed     Text format    


  242. NORTAMO S, Ukkola O, Lepojarvi S, Kentta T, et al
    Association of sST2 and hs-CRP levels with new-onset atrial fibrillation in coronary artery disease.
    Int J Cardiol. 2017;248:173-178.
    PubMed     Text format     Abstract available


  243. LIMONGELLI G, Sarubbi B
    Atrial arrhythmias in adults with congenital heart disease. Listening to your heart sound can save your life.
    Int J Cardiol. 2017;248:159-160.
    PubMed     Text format    


    November 2017
  244. REUSSER A, Blum S, Aeschbacher S, Eggimann L, et al
    QTc interval, cardiovascular events and mortality in patients with atrial fibrillation.
    Int J Cardiol. 2017 Nov 24. pii: S0167-5273(17)35267.
    PubMed     Text format     Abstract available


  245. STROKER E, Kupics K, de Asmundis C, Mugnai G, et al
    Atrial fibrillation ablation with the second generation cryoballoon: Multicenter propensity score matched comparison between freezing strategies.
    Int J Cardiol. 2017 Nov 22. pii: S0167-5273(17)35978.
    PubMed     Text format     Abstract available


  246. PERTICONE M, Sciacqua A, Tripepi G, Miceli S, et al
    Competitive interaction between chronic obstructive pulmonary disease and CHA2DS2-VASc score in predicting incident atrial fibrillation.
    Int J Cardiol. 2017 Nov 20. pii: S0167-5273(17)34491.
    PubMed     Text format     Abstract available


  247. YUCEL O, Yucel H, Zorlu A
    D-dimer is a predictor of cardiovascular death, and new-onset atrial fibrillation in patients with systolic heart failure.
    Int J Cardiol. 2017;247:39.
    PubMed     Text format    


  248. FOSSATI C, Volterrani M, Punzo N, Campolongo G, et al
    Dose-dependent effects of ivabradine on heart rate during maximal efforts in a woman with permanent atrial fibrillation.
    Int J Cardiol. 2017;247:37.
    PubMed     Text format    


  249. BAI F, Qin F, Liu Q, Tu T, et al
    Is the increased risk of thromboembolic events in adult congenital heart disease patients with atrial tachyarrhythmias accurate?
    Int J Cardiol. 2017;247:23.
    PubMed     Text format    


  250. MERT KU, Dural M, Mert GO
    Is electrical cardioversion doable in atrial fibrillation without transesophageal echocardiography?
    Int J Cardiol. 2017;247:20.
    PubMed     Text format    


  251. MAKOWSKI M, Baj Z
    New biomarkers in risk stratification in patients with atrial fibrillation.
    Int J Cardiol. 2017;247:19.
    PubMed     Text format    


  252. BARKAS F, Elisaf M, Liberopoulos E
    Low high-density lipoprotein cholesterol levels improve the performance of the CHADS2 and CHA2DS2-VASc scores for the prediction of new-onset atrial fibrillation.
    Int J Cardiol. 2017;247:18.
    PubMed     Text format    


  253. QIN F, Zhao Y, He B, Liu Q, et al
    Could low high-density lipoprotein cholesterol levels improve the performance of the CHADS2 and CHA2DS2-VASc scores in predicting new atrial fibrillation?
    Int J Cardiol. 2017;247:17.
    PubMed     Text format    


  254. LIU Q, Qin F, Liu N, Tu T, et al
    Is the new risk factor algorithm accurate to predict frequent premature ventricular contraction-induced cardiomyopathy?
    Int J Cardiol. 2017;247:27.
    PubMed     Text format    


  255. PHILLIPS KP
    Response by Phillips KP et al. to letter regarding article 'Long term outcomes from catheter ablation of very longstanding persistent atrial fibrillation'.
    Int J Cardiol. 2017;247:22.
    PubMed     Text format    


  256. MAURIZI N, Olivotto I, Cecchi F
    Reply to: Is subcutaneous implantable cardioverter-defibrillator testing effective and safe for patients with hypertrophic cardiomyopathy?
    Int J Cardiol. 2017;246:55.
    PubMed     Text format    


  257. QIN F, Liu Q, Liu Z
    Is subcutaneous implantable cardioverter-defibrillator testing effective and safe for patients with hypertrophic cardiomyopathy?
    Int J Cardiol. 2017;246:54.
    PubMed     Text format    


  258. EL-BATTRAWY I, Borggrefe M, Akin I
    Atrial fibrillation as a risk factor for worse outcome in acute coronary syndrome.
    Int J Cardiol. 2017;246:53.
    PubMed     Text format    


  259. GALLAGHER C, Hendriks JML, Elliott AD, Wong CX, et al
    Alcohol and incident atrial fibrillation - A systematic review and meta-analysis.
    Int J Cardiol. 2017;246:46-52.
    PubMed     Text format     Abstract available


    October 2017
  260. PAGOLA J, Juega J, Francisco-Pascual J, Moya A, et al
    Yield of atrial fibrillation detection with Textile Wearable Holter from the acute phase of stroke: Pilot study of Crypto-AF registry.
    Int J Cardiol. 2017 Oct 22. pii: S0167-5273(17)33896.
    PubMed     Text format     Abstract available


  261. GILLJAM T, Haugaa KH, Jensen HK, Svensson A, et al
    Heart transplantation in arrhythmogenic right ventricular cardiomyopathy - Experience from the Nordic ARVC Registry.
    Int J Cardiol. 2017 Oct 21. pii: S0167-5273(17)34381.
    PubMed     Text format     Abstract available


  262. POLIN B, Behar N, Galand V, Auffret V, et al
    Clinical predictors of challenging atrioventricular node ablation procedure for rate control in patients with atrial fibrillation.
    Int J Cardiol. 2017;245:168-173.
    PubMed     Text format     Abstract available


  263. LAHEWALA S, Arora S, Patel P, Kumar V, et al
    Atrial fibrillation: Utility of CHADS2 and CHA2DS2-VASc scores as predictors of readmission, mortality and resource utilization.
    Int J Cardiol. 2017;245:162-167.
    PubMed     Text format     Abstract available


  264. TSE G, Lip GYH, Liu T
    The CHADS2 and CHA2DS2-VASc scores for predicting healthcare utilization and outcomes: Observations on the Appropriate Use and Misuse of Risk scores.
    Int J Cardiol. 2017;245:181-182.
    PubMed     Text format    


  265. TADROS R, Wilde AAM
    Revisiting the sensitivity of sodium channel blocker testing in Brugada syndrome using obligate transmittance.
    Int J Cardiol. 2017;245:183-184.
    PubMed     Text format    


  266. ALHEDE C, Lauridsen TK, Johannessen A, Dixen U, et al
    The impact of supraventricular ectopic complexes in different age groups and risk of recurrent atrial fibrillation after antiarrhythmic medication or catheter ablation.
    Int J Cardiol. 2017 Oct 9. pii: S0167-5273(17)33443.
    PubMed     Text format     Abstract available


  267. LEINONEN JT, Crotti L, Djupsjobacka A, Castelletti S, et al
    The genetics underlying idiopathic ventricular fibrillation: A special role for catecholaminergic polymorphic ventricular tachycardia?
    Int J Cardiol. 2017 Oct 5. pii: S0167-5273(17)34464.
    PubMed     Text format     Abstract available


  268. BANERAS J, Ferreira-Gonzalez I, Marsal JR, Barrabes JA, et al
    Short-term exposure to air pollutants increases the risk of ST elevation myocardial infarction and of infarct-related ventricular arrhythmias and mortality.
    Int J Cardiol. 2017 Oct 5. pii: S0167-5273(17)34210.
    PubMed     Text format     Abstract available


  269. TSE G, Wong CW, Gong M, Wong WT, et al
    Predictive value of inter-atrial block for new onset or recurrent atrial fibrillation: A systematic review and meta-analysis.
    Int J Cardiol. 2017 Oct 3. pii: S0167-5273(17)35239.
    PubMed     Text format     Abstract available


  270. AGNIHOTRI K, Pothineni NV, Charilaou P, Vaidya VR, et al
    Impact of atrial fibrillation on outcomes with motor vehicle accidents.
    Int J Cardiol. 2017 Oct 3. pii: S0167-5273(17)33412.
    PubMed     Text format     Abstract available


  271. MAKOWSKI M, Baj Z
    Platelet reactivity and mean platelet volume as new biomarkers in risk stratification in patient with atrial fibrillation.
    Int J Cardiol. 2017;244:297.
    PubMed     Text format    


  272. WANG S, Li J, Yan G, Zhang Y, et al
    New biomarkers' improvement of thrombogenesis risk stratification in patients with atrial fibrillation and CHA2DS2-VASc Score 1.
    Int J Cardiol. 2017;244:296.
    PubMed     Text format    


  273. ZHAO Y, Qin F, He B, Liu X, et al
    Is atrial fibrillation itself the cause of increased platelet reactivity intrinsically?
    Int J Cardiol. 2017;244:205.
    PubMed     Text format    


  274. MAKOWSKI M, Baj Z
    Platelet reactivity and mean platelet volume as risk markers of thrombogenesis in atrial fibrillation.
    Int J Cardiol. 2017;244:204.
    PubMed     Text format    


  275. HEIJMAN J, Dobrev D, Crijns HJGM
    Targeting supraventricular ectopic complexes: Which approach should be used and how does it affect atrial fibrillation?
    Int J Cardiol. 2017;244:202-203.
    PubMed     Text format    


    September 2017
  276. DENAS G, Gennaro N, Ferroni E, Fedeli U, et al
    Effectiveness and safety of oral anticoagulation with non-vitamin K antagonists compared to well-managed vitamin K antagonists in naive patients with non-valvular atrial fibrillation: Propensity score matched cohort study.
    Int J Cardiol. 2017 Sep 18. pii: S0167-5273(17)32377.
    PubMed     Text format     Abstract available


  277. POLOVINA M, Dikic D, Vlajkovic A, Vilotijevic M, et al
    Adverse cardiovascular outcomes in atrial fibrillation: Validation of the new 2MACE risk score.
    Int J Cardiol. 2017 Sep 18. pii: S0167-5273(17)34881.
    PubMed     Text format     Abstract available


  278. YAMADA S, Lo LW, Chen SA
    Reply to letter to the editor: "A potential and lionhearted soldier for atrial fibrillation accompanied with heart failure: Renal denervation".
    Int J Cardiol. 2017;243:282.
    PubMed     Text format    


  279. YI X, Feng G, Jiang X
    A potential and lionhearted soldier for atrial fibrillation accompanied with heart failure: Renal denervation.
    Int J Cardiol. 2017;243:281.
    PubMed     Text format    


  280. WAKILI R, Dobrev D
    Role of triggers and substrate in heart failure based atrial fibrillation: Is pulmonary vein isolation still the cornerstone of atrial fibrillation therapy?
    Int J Cardiol. 2017;243:276-278.
    PubMed     Text format    


  281. HUIKURI HV
    Prediction of benefits from prophylactic implantable cardioverter-defibrillator therapy.
    Int J Cardiol. 2017;243:274-275.
    PubMed     Text format    


  282. FENDER AC, Dobrev D
    Dynamic balance of platelet reactivity in atrial fibrillation PARtially unravelled.
    Int J Cardiol. 2017;243:272-273.
    PubMed     Text format    


  283. DAN GA
    Atrial fibrillation: Applying evidence out of the box.
    Int J Cardiol. 2017;243:270-271.
    PubMed     Text format    


  284. SALIH M, Smer A, Charnigo R, Ayan M, et al
    Colchicine for prevention of post-cardiac procedure atrial fibrillation: Meta-analysis of randomized controlled trials.
    Int J Cardiol. 2017;243:258-262.
    PubMed     Text format     Abstract available


  285. POURTAU L, Sellal JM, Lacroix R, Poncelet P, et al
    Platelet function and microparticle levels in atrial fibrillation: Changes during the acute episode.
    Int J Cardiol. 2017;243:216-222.
    PubMed     Text format     Abstract available


  286. RODRIGUEZ-MANERO M, Lopez-Pardo E, Cordero A, Kredieh O, et al
    Clinical profile and outcomes in octogenarians with atrial fibrillation: A community-based study in a specific European health care area.
    Int J Cardiol. 2017;243:211-215.
    PubMed     Text format     Abstract available


  287. KAWAJI T, Shizuta S, Morimoto T, Aizawa T, et al
    Very long-term clinical outcomes after radiofrequency catheter ablation for atrial fibrillation: A large single-center experience.
    Int J Cardiol. 2017 Sep 15. pii: S0167-5273(17)33302.
    PubMed     Text format     Abstract available


  288. AYUBI E, Safiri S
    Comments on CHA2DS2-VASc score in the prediction of ischemic bowel disease among patients with atrial fibrillation.
    Int J Cardiol. 2017;242:9.
    PubMed     Text format    


  289. YANG Y, Liu Q, Liu Z, Zhou S, et al
    Is flat QRS complex in lead aVL the characteristic of ventricular arrhythmias originating from the junction of the right ventricular outflow tract and tricuspid annulus?
    Int J Cardiol. 2017;242:47.
    PubMed     Text format    


  290. NEEFS J, van den Berg NWE, Limpens J, Berger WR, et al
    Response to "comment on "aldosterone pathway blockade to prevent atrial fibrillation: A systematic review and meta-analysis" by Neefs et al."
    Int J Cardiol. 2017;242:23.
    PubMed     Text format    


  291. ALEXANDRE J, Sezai A, Milliez P
    Comment on "Aldosterone pathway blockade to prevent atrial fibrillation: A systematic review and meta-analysis" by Neefs et al.
    Int J Cardiol. 2017;242:22.
    PubMed     Text format    


  292. HU WS, Lin CL
    Reply: CHA2DS2-VASc score in the prediction of ischemic bowel disease among patients with atrial fibrillation: Insights from a nationwide cohort.
    Int J Cardiol. 2017;242:10.
    PubMed     Text format    


  293. LENNERZ C, Barman M, Tantawy M, Sopher M, et al
    Colchicine for primary prevention of atrial fibrillation after open-heart surgery: Systematic review and meta-analysis.
    Int J Cardiol. 2017 Sep 1. pii: S0167-5273(17)32407.
    PubMed     Text format     Abstract available


  294. WEI X, An Q
    Prognostic value of left atrial size and function in adults with tetralogy of Fallot.
    Int J Cardiol. 2017;242:36.
    PubMed     Text format    


    August 2017
  295. PROIETTI M, Laroche C, Nyvad O, Haberka M, et al
    Use of statins and adverse outcomes in patients with atrial fibrillation: An analysis from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) general registry pilot phase.
    Int J Cardiol. 2017 Aug 26. pii: S0167-5273(17)32291.
    PubMed     Text format     Abstract available


  296. GLOEKLER S, Saw J, Koskinas KC, Kleinecke C, et al
    Left atrial appendage closure for prevention of death, stroke, and bleeding in patients with nonvalvular atrial fibrillation.
    Int J Cardiol. 2017 Aug 26. pii: S0167-5273(17)33620.
    PubMed     Text format     Abstract available


  297. BELHASSEN B, Milman A
    Syncope in Brugada syndrome: A plea for thorough anamnesis and EPS. The lessons from our journey in the region of Piedmont, Italy.
    Int J Cardiol. 2017;241:241-242.
    PubMed     Text format    


  298. RHODES AC, Murray B, Tichnell C, James CA, et al
    Quality of life metrics in arrhythmogenic right ventricular cardiomyopathy patients: The impact of age, shock and sex.
    Int J Cardiol. 2017 Aug 14. pii: S0167-5273(17)31856.
    PubMed     Text format     Abstract available


  299. WANG M, Li S, Zhou X, Huang B, et al
    Increased inflammation promotes ventricular arrhythmia through aggravating left stellate ganglion remodeling in a canine ischemia model.
    Int J Cardiol. 2017 Aug 12. pii: S0167-5273(17)31266.
    PubMed     Text format     Abstract available


  300. DE LUCA L, Casella G, Rubboli A, Gonzini L, et al
    Recent trends in management and outcome of patients with acute coronary syndromes and atrial fibrillation.
    Int J Cardiol. 2017 Aug 10. pii: S0167-5273(17)32498.
    PubMed     Text format     Abstract available


  301. MASUDA K, Ishizu T, Gosho M, Aonuma K, et al
    Reply to: Increased risk of thromboembolic events in adult congenital heart disease patients with atrial tachyarrhythmias: Bias due to the data sparsity.
    Int J Cardiol. 2017 Aug 8. pii: S0167-5273(17)33784.
    PubMed     Text format    


  302. DOMINGUEZ F, Climent V, Zorio E, Ripoll-Vera T, et al
    Direct oral anticoagulants in patients with hypertrophic cardiomyopathy and atrial fibrillation.
    Int J Cardiol. 2017 Aug 7. pii: S0167-5273(17)33243.
    PubMed     Text format     Abstract available


  303. SABERIAN S, Badin A, Siebert V, Roy A, et al
    Prevalence and predictors of inappropriate anticoagulation in patients with a CHA2DS2-VASc score of 0 and atrial fibrillation.
    Int J Cardiol. 2017 Aug 2. pii: S0167-5273(17)31619.
    PubMed     Text format     Abstract available


  304. TINKER A
    The mechanisms of ventricular arrhythmia in Chagas disease.
    Int J Cardiol. 2017;240:372-373.
    PubMed     Text format    


  305. WALDO AL
    Atrial fibrillation and atrial flutter: Two sides of the same coin!
    Int J Cardiol. 2017;240:251-252.
    PubMed     Text format    


  306. ROMERO J, Estrada R, Holmes A, Goodman-Meza D, et al
    Atrial fibrillation inducibility during cavo-tricuspid isthmus dependent atrial flutter ablation for the prediction of clinical atrial fibrillation.
    Int J Cardiol. 2017;240:246-250.
    PubMed     Text format     Abstract available


    July 2017
  307. LEE SR, Choi EK, Han KD, Cha MJ, et al
    Association between gamma-glutamyltransferase level and incidence of atrial fibrillation: A nationwide population-based study.
    Int J Cardiol. 2017 Jul 21. pii: S0167-5273(16)34879.
    PubMed     Text format     Abstract available


  308. KANG SH, Kim J, Park JJ, Oh IY, et al
    Risk of stroke in congestive heart failure with and without atrial fibrillation.
    Int J Cardiol. 2017 Jul 20. pii: S0167-5273(17)30701.
    PubMed     Text format     Abstract available


  309. STIERMAIER T, Santoro F, Eitel C, Graf T, et al
    Prevalence and prognostic relevance of atrial fibrillation in patients with Takotsubo syndrome.
    Int J Cardiol. 2017 Jul 18. pii: S0167-5273(17)33182.
    PubMed     Text format     Abstract available


  310. ZHANG N, Tse G, Liang X, Li G, et al
    Telomere length: A newly marker for predicting atrial fibrillation?
    Int J Cardiol. 2017;239:21.
    PubMed     Text format    


  311. AYUBI E, Safiri S, Mansournia MA
    Increased risk of thromboembolic events in adult congenital heart disease patients with atrial tachyarrhythmias: Bias due to the data sparsity.
    Int J Cardiol. 2017;239:20.
    PubMed     Text format    


  312. ZENG J, Wang X
    Metabolic disorder caused by antipsychotic treatment may facilitate the development of atrial fibrillation.
    Int J Cardiol. 2017;239:14.
    PubMed     Text format    


  313. ROSATO E, Tubani L, Gigante A
    QTc interval prolongation in systemic sclerosis.
    Int J Cardiol. 2017;239:34.
    PubMed     Text format    


  314. DE LUCA G, Bosello SL, Canestrari G, Cavalli G, et al
    QTc interval prolongation in Systemic Sclerosis: Correlations with clinical variables and arrhythmic risk.
    Int J Cardiol. 2017;239:33.
    PubMed     Text format    


  315. CERIT L
    Dual risk stratification for dual antiplatelet therapy: SYNTAX and CHA2DS2-VASc score.
    Int J Cardiol. 2017;239:22.
    PubMed     Text format    


  316. NOSEWORTHY PA, Yao X, Gersh BJ, Hargraves I, et al
    Long-term stroke and bleeding risk in patients with atrial fibrillation treated with oral anticoagulants in contemporary practice: Providing evidence for shared decision-making.
    Int J Cardiol. 2017 Jul 14. pii: S0167-5273(17)32969.
    PubMed     Text format     Abstract available


  317. BAYKANER T, Zaman JAB, Rogers AJ, Navara R, et al
    Spatial relationship of sites for atrial fibrillation drivers and atrial tachycardia in patients with both arrhythmias.
    Int J Cardiol. 2017 Jul 14. pii: S0167-5273(17)31816.
    PubMed     Text format     Abstract available


  318. SUN C, Qin F, Tu T, Liu Q, et al
    Is antiarrhythmic medication superior to catheter ablation in suppressing supraventricular ectopic complexes in patients with atrial fibrillation?
    Int J Cardiol. 2017 Jul 6. pii: S0167-5273(17)33752.
    PubMed     Text format    


  319. AZADANI PN, King JB, Kheirkhahan M, Chang L, et al
    Left atrial fibrosis is associated with new-onset heart failure in patients with atrial fibrillation.
    Int J Cardiol. 2017 Jul 5. pii: S0167-5273(17)32655.
    PubMed     Text format    


    June 2017
  320. CHOU RH, Lo LW, Leu HB
    Autonomic dysfunction plays a decisive role in the arrhythmia initiation, whereas metabolic disorders facilitate further atrial remodeling in antipsychotic-related atrial fibrillation.
    Int J Cardiol. 2017 Jun 30. pii: S0167-5273(17)30750.
    PubMed     Text format    


  321. OKAWA K, Miyoshi T, Tsukuda S, Hara S, et al
    Differences in endothelial dysfunction induced by paroxysmal and persistent atrial fibrillation: Insights from restoration of sinus rhythm by catheter ablation.
    Int J Cardiol. 2017 Jun 19. pii: S0167-5273(17)32623.
    PubMed     Text format     Abstract available


  322. CROTTI L, Kotta MC
    The role of genetics in primary ventricular fibrillation, inherited channelopathies and cardiomyopathies.
    Int J Cardiol. 2017;237:45-48.
    PubMed     Text format     Abstract available


  323. MIYAZAKI S, Ebana Y, Liu L, Nakamura H, et al
    Chromosome 4q25 variants and recurrence after second-generation cryoballoon ablation in patients with paroxysmal atrial fibrillation.
    Int J Cardiol. 2017 Jun 15. pii: S0167-5273(17)30813.
    PubMed     Text format     Abstract available


  324. STYLES K, Sapp J Jr, Gardner M, Gray C, et al
    The influence of sex and age on ventricular arrhythmia in a population-based registry.
    Int J Cardiol. 2017 Jun 13. pii: S0167-5273(17)32392.
    PubMed     Text format     Abstract available


  325. HOLDA MK, Koziej M, Wszolek K, Pawlik W, et al
    Left atrial accessory appendages, diverticula, and left-sided septal pouch in multi-slice computed tomography. Association with atrial fibrillation and cerebrovascular accidents.
    Int J Cardiol. 2017 Jun 13. pii: S0167-5273(17)32424.
    PubMed     Text format     Abstract available


  326. ZIEGLER PD, Rogers JD, Ferreira SW, Nichols AJ, et al
    Long-term detection of atrial fibrillation with insertable cardiac monitors in a real-world cryptogenic stroke population.
    Int J Cardiol. 2017 Jun 10. pii: S0167-5273(17)32506.
    PubMed     Text format     Abstract available


  327. ELLERMANN C, Wolfes J, Kochhauser S, Dechering DG, et al
    Divergent antiarrhythmic effects of resveratrol and piceatannol in a whole-heart model of long QT syndrome.
    Int J Cardiol. 2017 Jun 3. pii: S0167-5273(17)32130.
    PubMed     Text format     Abstract available


  328. CARMO J, Ferreira J, Costa F, Carmo P, et al
    Non-vitamin K antagonist oral anticoagulants compared with warfarin at different levels of INR control in atrial fibrillation: A meta-analysis of randomized trials.
    Int J Cardiol. 2017 Jun 3. pii: S0167-5273(17)31600.
    PubMed     Text format     Abstract available


  329. CHANG KW, Arbit B, Hsu JC
    Antithrombotic regimens in patients with atrial fibrillation and coronary artery disease after percutaneous coronary intervention: A focused review.
    Int J Cardiol. 2017 Jun 2. pii: S0167-5273(17)32256.
    PubMed     Text format     Abstract available


  330. STEFFEL J, Ruff CT, Hamershock RA, Murphy SA, et al
    First experience with edoxaban and atrial fibrillation ablation - Insights from the ENGAGE AF-TIMI 48 trial.
    Int J Cardiol. 2017 Jun 2. pii: S0167-5273(17)32088.
    PubMed     Text format     Abstract available


  331. BELLMANN B, Fiebach JB, Guttmann S, Lin T, et al
    Incidence of MRI-detected brain lesions and neurocognitive function after electrical cardioversion in anticoagulated patients with persistent atrial fibrillation.
    Int J Cardiol. 2017 Jun 1. pii: S0167-5273(17)32336.
    PubMed     Text format     Abstract available


  332. D'ANGELO RN, Pickett CC
    Diagnostic yield of device interrogation in the evaluation of syncope in an elderly population.
    Int J Cardiol. 2017;236:164-167.
    PubMed     Text format     Abstract available


  333. LUO B, Zhou G, Guo X, Liu X, et al
    Long-term outcome of catheter ablation for left posterior fascicular ventricular tachycardia with the development of left posterior fascicular block and characteristics of repeat procedures.
    Int J Cardiol. 2017;236:203-208.
    PubMed     Text format     Abstract available


  334. TURAGAM MK, Afzal MR, Reddy M, Pillarisetti J, et al
    Practice variation in the re-initiation of dofetilide: An observational study.
    Int J Cardiol. 2017;236:221-225.
    PubMed     Text format     Abstract available


  335. CHANG JH, Chang SL, Hong PD, Chen PN, et al
    Epigallocatechin-3-gallate modulates arrhythmogenic activity and calcium homeostasis of left atrium.
    Int J Cardiol. 2017;236:174-180.
    PubMed     Text format     Abstract available


  336. HAMMWOHNER M, Goette A
    Kidney diseases and NOAC therapy: Is there a light at the end of the tunnel?
    Int J Cardiol. 2017;236:162-163.
    PubMed     Text format    


    May 2017
  337. MATUSIK PT, Matusik PS, Kornacewicz-Jach Z, Malecka B, et al
    Elevated NT-proBNP is associated with unfavorably altered plasma fibrin clot properties in atrial fibrillation.
    Int J Cardiol. 2017 May 16. pii: S0167-5273(17)31785.
    PubMed     Text format     Abstract available


  338. DA COSTA A, Guichard JB, Romeyer-Bouchard C
    Reply to the letter to Editor "Is hybrid subcutaneous implantable cardioverter-defibrillator and leadless pacemaker the future of device therapy?"
    Int J Cardiol. 2017;235:202.
    PubMed     Text format    


  339. LIANG J, Cha Y
    Is hybrid subcutaneous implantable cardioverter-defibrillator and leadless pacemaker the future of device therapy?
    Int J Cardiol. 2017;235:201.
    PubMed     Text format    


  340. MALLIKETHI-REDDY S, Akintoye E, Trehan N, Sharma S, et al
    Burden of arrhythmias in peripartum cardiomyopathy: Analysis of 9841 hospitalizations.
    Int J Cardiol. 2017;235:114-117.
    PubMed     Text format     Abstract available


  341. TAKAHASHI Y, Izumi C, Miyake M, Imanaka M, et al
    Actual management and prognosis of severe isolated tricuspid regurgitation associated with atrial fibrillation without structural heart disease.
    Int J Cardiol. 2017 May 11. pii: S0167-5273(16)32716.
    PubMed     Text format     Abstract available


  342. ALHEDE C, Lauridsen TK, Johannessen A, Dixen U, et al
    Antiarrhythmic medication is superior to catheter ablation in suppressing supraventricular ectopic complexes in patients with atrial fibrillation.
    Int J Cardiol. 2017 May 10. pii: S0167-5273(17)31514.
    PubMed     Text format     Abstract available


  343. CASTELLETTI S, Vischer AS, Syrris P, Crotti L, et al
    Desmoplakin missense and non-missense mutations in arrhythmogenic right ventricular cardiomyopathy: Genotype-phenotype correlation.
    Int J Cardiol. 2017 May 10. pii: S0167-5273(17)30578.
    PubMed     Text format     Abstract available


  344. WONG CX, Gan SW, Lee SW, Gallagher C, et al
    Atrial fibrillation and risk of hip fracture: A population-based analysis of 113,600 individuals.
    Int J Cardiol. 2017 May 5. pii: S0167-5273(16)34388.
    PubMed     Text format     Abstract available


    April 2017
  345. LIU J, Wang N, Qin L, Liu J, et al
    Integrating genotypes in the SAMe-TT2R2 score for the prediction of anticoagulation control in Chinese patients with atrial fibrillation on warfarin.
    Int J Cardiol. 2017 Apr 29. pii: S0167-5273(17)30949.
    PubMed     Text format     Abstract available


  346. SUNDBOLL J, Hovath-Puho E, Adelborg K, Ording A, et al
    Risk of arterial and venous thromboembolism in patients with atrial fibrillation or flutter: A nationwide population-based cohort study.
    Int J Cardiol. 2017 Apr 26. pii: S0167-5273(17)30248.
    PubMed     Text format     Abstract available


  347. XIE J, Chahal CAA, Covassin N, Schulte PJ, et al
    Periodic limb movements of sleep are associated with an increased prevalence of atrial fibrillation in patients with mild sleep-disordered breathing.
    Int J Cardiol. 2017 Apr 22. pii: S0167-5273(16)34493.
    PubMed     Text format     Abstract available


  348. KIMURA Y, Noda T, Matsuyama TA, Otsuka Y, et al
    Heart failure in patients with arrhythmogenic right ventricular cardiomyopathy: What are the risk factors?
    Int J Cardiol. 2017 Apr 21. pii: S0167-5273(17)30192.
    PubMed     Text format     Abstract available


  349. HUNG Y, Lo LW, Lin YJ, Chang SL, et al
    Characteristics and long-term catheter ablation outcome in long-standing persistent atrial fibrillation patients with non-pulmonary vein triggers.
    Int J Cardiol. 2017 Apr 21. pii: S0167-5273(16)33852.
    PubMed     Text format     Abstract available


  350. BARKAS F, Elisaf M, Korantzopoulos P, Tsiara S, et al
    The CHADS2 and CHA2DS2-VASc scores predict atrial fibrillation in dyslipidemic individuals: Role of incorporating low high-density lipoprotein cholesterol levels.
    Int J Cardiol. 2017 Apr 20. pii: S0167-5273(17)31069.
    PubMed     Text format     Abstract available


  351. HATEGAN L, Csanyi B, Ordog B, Kakonyi K, et al
    A novel 'splice site' HCN4 Gene mutation, c.1737+1 G>T, causes familial bradycardia, reduced heart rate response, impaired chronotropic competence and increased short-term heart rate variability.
    Int J Cardiol. 2017 Apr 20. pii: S0167-5273(17)30089.
    PubMed     Text format     Abstract available


  352. BAYKANER T, Zografos TA, Zaman JAB, Pantos I, et al
    Spatial relationship of organized rotational and focal sources in human atrial fibrillation to autonomic ganglionated plexi.
    Int J Cardiol. 2017 Apr 19. pii: S0167-5273(17)30158.
    PubMed     Text format     Abstract available


  353. O'BRIEN B, Zafar H, De Freitas S, Sharif F, et al
    Transseptal puncture - Review of anatomy, techniques, complications and challenges.
    Int J Cardiol. 2017;233:12-22.
    PubMed     Text format     Abstract available


  354. PARK KM, Im SI, Park SJ, Kim JS, et al
    Risk factor algorithm used to predict frequent premature ventricular contraction-induced cardiomyopathy.
    Int J Cardiol. 2017;233:37-42.
    PubMed     Text format     Abstract available


  355. SPITZER SG, Leitz P, Langbein A, Karolyi L, et al
    Circumferential pulmonary vein isolation with second-generation multipolar catheter in patients with paroxysmal or persistent atrial fibrillation: Procedural and one-year follow-up results.
    Int J Cardiol. 2017 Apr 12. pii: S0167-5273(16)34442.
    PubMed     Text format     Abstract available


  356. YAMASAKI H, Lustgarten D, Cerkvenik J, Birnie D, et al
    Adaptive CRT in patients with normal AV conduction and left bundle branch block: Does QRS duration matter?
    Int J Cardiol. 2017 Apr 12. pii: S0167-5273(16)33104.
    PubMed     Text format     Abstract available


  357. MURA M, Mehta A, Ramachandra CJ, Zappatore R, et al
    The KCNH2-IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by Long QT Syndrome type 2.
    Int J Cardiol. 2017 Apr 12. pii: S0167-5273(17)30298.
    PubMed     Text format     Abstract available


  358. ANSELMINO M, Garberoglio L, Gili S, Bertaglia E, et al
    Left atrial appendage thrombi relate to easily accessible clinical parameters in patients undergoing atrial fibrillation transcatheter ablation: A multicenter study.
    Int J Cardiol. 2017 Apr 8. pii: S0167-5273(16)32868.
    PubMed     Text format     Abstract available


  359. ARENAS DE LARRIVA AP, Norby FL, Chen LY, Soliman EZ, et al
    Circulating ceruloplasmin, ceruloplasmin-associated genes, and the incidence of atrial fibrillation in the atherosclerosis risk in communities study.
    Int J Cardiol. 2017 Apr 6. pii: S0167-5273(16)34419.
    PubMed     Text format     Abstract available


  360. MERY B, Guichard JB, Guy JB, Vallard A, et al
    Atrial fibrillation in cancer patients: Hindsight, insight and foresight.
    Int J Cardiol. 2017 Apr 5. pii: S0167-5273(17)30307.
    PubMed     Text format     Abstract available


  361. TANG LH, Kikkenborg Berg S, Christensen J, Lawaetz J, et al
    Patients' preference for exercise setting and its influence on the health benefits gained from exercise-based cardiac rehabilitation.
    Int J Cardiol. 2017;232:33-39.
    PubMed     Text format     Abstract available


  362. KOSTIC T, Momcilovic S, Perisic ZD, Apostolovic SR, et al
    Manifestations of Lyme carditis.
    Int J Cardiol. 2017;232:24-32.
    PubMed     Text format     Abstract available


  363. ABRICH VA, Ramakrishna H, Mehta A, Mookadam F, et al
    The possible role of propofol in drug-induced torsades de pointes: A real-world single-center analysis.
    Int J Cardiol. 2017;232:243-246.
    PubMed     Text format     Abstract available


    March 2017
  364. KIM IS, Sohn J, Lee SJ, Park JK, et al
    Association of air pollution with increased incidence of ventricular tachyarrhythmias recorded by implantable cardioverter defibrillators: Vulnerable patients to air pollution.
    Int J Cardiol. 2017 Mar 30. pii: S0167-5273(17)30052.
    PubMed     Text format     Abstract available


  365. LEE H, Choi EK, Lee SH, Han KD, et al
    Atrial fibrillation risk in metabolically healthy obesity: A nationwide population-based study.
    Int J Cardiol. 2017 Mar 28. pii: S0167-5273(16)32706.
    PubMed     Text format     Abstract available


  366. BRUNETTI ND, De Gennaro L, Caldarola P, Gaglione A, et al
    Direct oral anticoagulants for the prevention of thromboembolic complications of atrial fibrillation: The more you pay, the less you spend?
    Int J Cardiol. 2017 Mar 22. pii: S0167-5273(17)31385.
    PubMed     Text format    


  367. FEMIA G, Sy RW, Puranik R
    Systematic review: Impact of the new task force criteria in the diagnosis of arrhythmogenic right ventricular cardiomyopathy.
    Int J Cardiol. 2017 Mar 19. pii: S0167-5273(17)30613.
    PubMed     Text format     Abstract available


  368. CAPPATO R, Ali H
    Sudden cardiac death: New approaches for implantable cardioverter-defibrillators (ICDs).
    Int J Cardiol. 2017 Mar 18. pii: S0167-5273(17)31691.
    PubMed     Text format     Abstract available


  369. CAMM AJ
    Hopes and disappointments with antiarrhythmic drugs.
    Int J Cardiol. 2017 Mar 16. pii: S0167-5273(17)31664.
    PubMed     Text format     Abstract available


  370. TOPAZ G, Flint N, Steinvil A, Finkelstein A, et al
    Long term prognosis of atrial fibrillation in ST-elevation myocardial infarction patients undergoing percutaneous coronary intervention.
    Int J Cardiol. 2017 Mar 16. pii: S0167-5273(16)32197.
    PubMed     Text format     Abstract available


  371. SCHWARTZ PJ, Dagradi F
    Red Bull(R): Red flag or red herring?
    Int J Cardiol. 2017;231:179-180.
    PubMed     Text format    


  372. LI H, Qingyao, Bingshen, Shu M, et al
    Application of 3D printing technology to left atrial appendage occlusion.
    Int J Cardiol. 2017;231:258-263.
    PubMed     Text format     Abstract available


  373. BIFFI M, Ziacchi M, Ricci RP, Facchin D, et al
    Can we predict new AF occurrence in single-chamber ICD patients? Insights from an observational investigation.
    Int J Cardiol. 2017;230:275-280.
    PubMed     Text format     Abstract available


  374. DA COSTA A, Guichard JB, Maillard N, Romeyer-Bouchard C, et al
    Substantial superiority of Niobe ES over Niobe II system in remote-controlled magnetic pulmonary vein isolation.
    Int J Cardiol. 2017;230:319-323.
    PubMed     Text format     Abstract available


  375. SUN GZ, Ye N, Chen YT, Zhou Y, et al
    Early repolarization pattern in the general population: Prevalence and associated factors.
    Int J Cardiol. 2017;230:614-618.
    PubMed     Text format     Abstract available


    February 2017
  376. YAMADA S, Lo LW, Chou YH, Lin WL, et al
    Renal denervation regulates the atrial arrhythmogenic substrates through reverse structural remodeling in heart failure rabbit model.
    Int J Cardiol. 2017 Feb 24. pii: S0167-5273(17)31114.
    PubMed     Text format     Abstract available


  377. CAY S, Aras D, Topaloglu S, Ozcan F, et al
    Early repolarization syndrome and Brugada syndrome: Similar or different?
    Int J Cardiol. 2017;229:9.
    PubMed     Text format    


  378. MODI R, Patted SV, Halkati PC, Porwal S, et al
    CHA2DS2-VASc-HSF score - New predictor of severity of coronary artery disease in 2976 patients.
    Int J Cardiol. 2017;228:1002-1006.
    PubMed     Text format     Abstract available


  379. PATEL N, Donahue C, Shenoy A, Patel A, et al
    Obstructive sleep apnea and arrhythmia: A systemic review.
    Int J Cardiol. 2017;228:967-970.
    PubMed     Text format     Abstract available


  380. YUAN X, Du J, Liu Q, Zhang L, et al
    Defining the role of perioperative statin treatment in patients after cardiac surgery: A meta-analysis and systematic review of 20 randomized controlled trials.
    Int J Cardiol. 2017;228:958-966.
    PubMed     Text format     Abstract available


  381. TE AL, Lin YJ, Chen YY, Chung FP, et al
    Increased risk of ventricular tachycardia in patients with sarcoidosis during the very long term follow-up.
    Int J Cardiol. 2017;228:68-73.
    PubMed     Text format     Abstract available


  382. FROMMEYER G, Kohnke A, Ellermann C, Dechering DG, et al
    Experimental evidence for a severe proarrhythmic potential of levosimendan.
    Int J Cardiol. 2017;228:583-587.
    PubMed     Text format     Abstract available


  383. LEE G, McLellan AJ, Hunter RJ, Lovell MJ, et al
    Panoramic characterization of endocardial left atrial activation during human persistent AF: Insights from non-contact mapping.
    Int J Cardiol. 2017;228:406-411.
    PubMed     Text format     Abstract available


  384. JUNELL A, Thomas J, Hawkins L, Sklenar J, et al
    Screening entire healthcare system ECG database: Association of deep terminal negativity of P wave in lead V1 and ECG referral with mortality.
    Int J Cardiol. 2017;228:219-224.
    PubMed     Text format     Abstract available


    January 2017
  385. ZACHARIASARDOTTIR S, Risgaard B, Agesen FN, Jabbari R, et al
    Sudden cardiac death and coronary disease in the young: A nationwide cohort study in Denmark.
    Int J Cardiol. 2017 Jan 28. pii: S0167-5273(16)33099.
    PubMed     Text format     Abstract available


  386. BOTTO GL, Padeletti L, Covino G, Pieragnoli P, et al
    Electrical treatment of atrial arrhythmias in heart failure patients implanted with a dual defibrillator CRT device. Results from the TRADE-HF study.
    Int J Cardiol. 2017 Jan 19. pii: S0167-5273(16)33105.
    PubMed     Text format     Abstract available


  387. BANERJEE K, Ghosh RK, Kamatam S, Banerjee A, et al
    Role of Ranolazine in cardiovascular disease and diabetes: Exploring beyond angina.
    Int J Cardiol. 2017;227:556-564.
    PubMed     Text format     Abstract available


  388. PADALA SK, Peaslee S, Sidhu MS, Steckman DA, et al
    Impact of early initiation of corticosteroid therapy on cardiac function and rhythm in patients with cardiac sarcoidosis.
    Int J Cardiol. 2017;227:565-570.
    PubMed     Text format     Abstract available


  389. CHO MS, Kwon CH, Nam GB, Lee WS, et al
    Characteristics of early repolarization parameters and prognostic implications in the general ambulatory Korean population.
    Int J Cardiol. 2017;227:571-576.
    PubMed     Text format     Abstract available


  390. DA COSTA A, Axiotis A, Romeyer-Bouchard C, Abdellaoui L, et al
    Transcatheter leadless cardiac pacing: The new alternative solution.
    Int J Cardiol. 2017;227:122-126.
    PubMed     Text format     Abstract available


  391. TONDATO F, Bazzell J, Schwartz L, Mc Donald BW, et al
    Safety and interaction of patients with implantable cardiac defibrillators driving a hybrid vehicle.
    Int J Cardiol. 2017;227:318-324.
    PubMed     Text format     Abstract available


  392. KIUCHI MG, Chen S, Purerfellner H
    Incidence of ventricular arrhythmic events in CKD patients with ICD.
    Int J Cardiol. 2017;227:312-317.
    PubMed     Text format     Abstract available


  393. KIMURA M, Fujisawa T, Aizawa Y, Matsuhashi N, et al
    An RyR2 mutation found in a family with a short-coupled variant of torsade de pointes.
    Int J Cardiol. 2017;227:367-369.
    PubMed     Text format    


  394. SEZAI A, Akahoshi T, Osaka S, Yaoita H, et al
    Sleep disordered breathing in cardiac surgery patients: The NU-SLEEP trial.
    Int J Cardiol. 2017;227:342-346.
    PubMed     Text format     Abstract available


  395. LI N, Wang Q, Sibrian-Vazquez M, Klipp RC, et al
    Treatment of catecholaminergic polymorphic ventricular tachycardia in mice using novel RyR2-modifying drugs.
    Int J Cardiol. 2017;227:668-673.
    PubMed     Text format     Abstract available


  396. CHIU SN, Wu WL, Lu CW, Wu KL, et al
    Special electrophysiological characteristics of pediatric idiopathic ventricular tachycardia.
    Int J Cardiol. 2017;227:595-601.
    PubMed     Text format     Abstract available


  397. CHANAVIRUT R, Tong-Un T, Jirakulsomchok D, Wyss JM, et al
    Abnormal autonomic nervous system function in rural Thai men: A potential contributor to their high risk of sudden unexplained nocturnal death syndrome.
    Int J Cardiol. 2017;226:87-92.
    PubMed     Text format     Abstract available


    December 2016
  398. CHANG KH, Chang WC, Su CS, Liu TJ, et al
    Vasospastic myocardial infarction complicated with ventricular tachycardia in a patient with hyperthyroidism.
    Int J Cardiol. 2016 Dec 27. pii: S0167-5273(16)32087.
    PubMed     Text format    


  399. BERTEL N, Witassek F, Puhan M, Erne P, et al
    Management and outcome of patients with acute myocardial infarction presenting with pacemaker rhythm.
    Int J Cardiol. 2016 Dec 20. pii: S0167-5273(16)34533.
    PubMed     Text format     Abstract available


    November 2016
  400. OMAR HR, Guglin M
    Mitral annulus diameter is the main echocardiographic correlate of S3 gallop in acute heart failure.
    Int J Cardiol. 2016;228:834-836.
    PubMed     Text format    


  401. ZHOU X, Cao K, Kou S, Qu S, et al
    Usefulness of CHADS2 score for prognostic stratification of patients with coronary artery disease: A systematic review and meta-analysis of cohort studies.
    Int J Cardiol. 2016;228:906-911.
    PubMed     Text format     Abstract available


  402. BECATTINI C, Franco L, Beyer-Westendorf J, Masotti L, et al
    Major bleeding with vitamin K antagonists or direct oral anticoagulants in real-life.
    Int J Cardiol. 2016 Nov 9. pii: S0167-5273(16)33576.
    PubMed     Text format     Abstract available


    September 2016
  403. LIN WL, Lo LW, Chen HR, Lai CT, et al
    Sleep-related changes in cardiovascular autonomic regulation in left coronary artery ligation rats: Neural mechanism facilitating arrhythmia after myocardial infarction.
    Int J Cardiol. 2016;225:65-72.
    PubMed     Text format     Abstract available


    August 2016
  404. ERGUN G, Dogan V, Basaran O, Biteker M, et al
    Metoprolol vs ivabradine in patients with mitral stenosis.
    Int J Cardiol. 2016;223:108.
    PubMed     Text format    


  405. AKIMA T, Koyama T, Munakata M, Shibata M, et al
    Absence of reperfusion-induced arrhythmia in patients with ST-segment elevation myocardial infarction treated using postconditioning with lactate-enriched blood.
    Int J Cardiol. 2016;222:780-781.
    PubMed     Text format    


    June 2016
  406. HONG-TAOYUAN, Yang M, Zhong L, Lee YH, et al
    Ventricular premature contraction associated with mitral valve prolapse.
    Int J Cardiol. 2016;221:1144-1149.
    PubMed     Text format     Abstract available


    April 2016
  407. SLAWUTA A, Mazur G, Malecka B, Gajek J, et al
    Permanent His bundle pacing - An optimal treatment method in heart failure patients with AF and narrow QRS.
    Int J Cardiol. 2016;214:451-452.
    PubMed     Text format    


    March 2016
  408. STEWART S, Riegel B, Boyd C, Ahamed Y, et al
    Establishing a pragmatic framework to optimise health outcomes in heart failure and multimorbidity (ARISE-HF): A multidisciplinary position statement.
    Int J Cardiol. 2016;212:1-10.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: